How we choose sources
UK medicine information starts with MHRA regulatory records and product-specific prescribing information. NICE and relevant NHS bodies inform clinical context; SIGN and the Scottish Medicines Consortium address their Scottish scopes. Guidance, authorisation, funding and availability are separate questions.
Relevant professional guidelines, Cochrane reviews, systematic reviews and original peer-reviewed studies add detail. PubMed indexing makes research discoverable; it does not prove a study is reliable. We assess the methods, population, relevance, limitations and date rather than relying on an organisation’s name alone.
Textbooks can explain foundations and history, but do not replace current prescribing guidance. Manufacturer material is supplementary and identified as such; it does not establish independent evidence. An original developer, current manufacturer and marketing-authorisation holder may be different organisations, and are named only when verified for the product and country.
Existing valid historical references are retained. Association is not causation, a proposed mechanism is not a proven explanation, and a preliminary finding is not clinical consensus. No linked organisation is represented as endorsing or partnering with Psychiatry Atlas.
Professional organisations and resources
A curated set of official websites, grouped by purpose. Listing is not affiliation or endorsement. Membership organisations are distinct from regulators. Check each service’s current eligibility, location, cost and availability.
Professional organisations and clinical guidance
- Royal College of Psychiatrists
UK professional medical body supporting psychiatrists, training, quality standards, research and mental-health public information.
- National Institute for Health and Care Excellence
Public body producing evidence-based health and care guidance for England. Use elsewhere in the UK depends on the guidance and each nation's arrangements.
- NHS website
Public information about conditions, medicines, treatments and accessing NHS services in England.
- Scottish Intercollegiate Guidelines Network
Develops evidence-based national clinical guidelines to support healthcare practice in Scotland.
- Scottish Medicines Consortium
Provides advice to NHSScotland on the clinical and cost-effectiveness of newly licensed medicines and selected new uses or formulations.
- Medicines and Healthcare products Regulatory Agency
UK regulator for medicines, medical devices and blood components, providing safety information and regulatory guidance.
Mental health information and support
Education, advocacy and peer support complement professional care; these links are not emergency services.
- Mind
Mental-health charity providing information, advocacy and peer support, with local Minds offering services across England and Wales.
- Rethink Mental Illness
Mental-health charity providing information, campaigning, local services and peer groups for people affected by mental illness and those who support them.
- Bipolar UK
UK charity providing bipolar information and peer support for people living with bipolar disorder and their families or friends.
- Anxiety UK
UK charity offering anxiety information, peer support, groups and access to therapy. Some services involve membership or fees.
- OCD-UK
UK charity offering OCD education, advice and peer support for UK residents, including resources for families.
- PTSD UK
UK charity raising awareness of PTSD and complex PTSD and providing information for affected people and their supporters.
- Beat Eating Disorders
UK eating-disorder charity offering information, support services and resources for affected people, families and friends.
Healthcare systems and policy research
Policy research describes healthcare systems. It does not replace NICE guidance or individual treatment decisions. England-specific findings are not automatically applicable to the other UK nations.
- The King's Fund
Independent charity conducting research and analysis on health and care, including services, access, inequalities and policy, with a focus on England.
Emergency and crisis resources are kept separately.
Product-specific UK information and national guidance are checked separately. Shared general scientific sources retain their original checking dates.
References
Sources and References
- ADHD: children and young people — Chelsea and Westminster Hospital NHS Foundation Trust. Checked 2026-10-17.
- ADHD in adults — NHS. Checked 2026-10-17.
- Attention deficit hyperactivity disorder: diagnosis and management — recommendations — NICE. Checked 2026-10-17.
- About this quality standard: national applicability — NICE. Checked 2026-10-17.
- ADHD: What You Need to Know — NIMH. Checked 2026-10-16.
- Understanding ADHD: what you need to know — NIH MedlinePlus Magazine. Checked 2026-10-16.
- Diagnosing ADHD — CDC. Checked 2026-10-16.
- Data on ADHD in Children — CDC. Checked 2026-10-16.
- Treatment of ADHD — CDC. Checked 2026-10-16.
- Attention deficit hyperactivity disorder: diagnosis and management (NG87) — NICE. Checked 2026-10-21.
- ADHD: full recommendations PDF — NICE. Checked 2026-10-30.
- ADHD: rationale and impact — NICE. Checked 2026-10-30.
- Depression in adults: overview — NHS. Checked 2026-10-17.
- NICE NG222: Depression in adults — treatment and management — NICE NG222. Checked 2026-10-19.
- Find NHS talking therapies for anxiety and depression — NHS. Checked 2026-10-17.
- Depression: treatment and brain stimulation options — National Institute of Mental Health. Checked 2026-10-19.
- DSM-IV to DSM-5 Major Depressive Episode/Disorder Comparison — SAMHSA. Checked 2026-10-16.
- Major Depression: 2021 survey estimates — NIMH. Checked 2026-10-16.
- Depression: What is depression? — NIH — NIMH. Checked 2026-10-16.
- NHS: Treatment — Depression in adults — NHS. Checked 2026-10-19.
- Depression in children and young people: identification and management (NG134) — NICE. Checked 2026-10-21.
- Depression in children and young people — recommendations — NICE. Checked 2026-10-30.
- Fluoxetine 20 mg Capsules: UK SmPC — Flamingo Pharma / emc. Checked 2026-10-17.
- Generalised anxiety disorder — NHS. Checked 2026-10-16.
- Panic disorder — NHS. Checked 2026-10-17.
- NICE CG113: Generalised anxiety disorder and panic disorder — NICE. Checked 2026-10-17.
- Generalized Anxiety Disorder: What You Need to Know — NIMH. Checked 2026-10-21.
- DSM-5 Child Mental Disorder Classification: generalized anxiety — SAMHSA. Checked 2026-10-16.
- Generalized Anxiety Disorder: NCS-R survey estimates — NIMH. Checked 2026-10-16.
- Anxiety Disorders — NIMH. Checked 2026-10-17.
- Chest pain: when to get emergency help — NHS. Checked 2026-10-21.
- Shortness of breath: severe breathing difficulty — NHS. Checked 2026-10-21.
- Anxiety disorders in children — NHS. Checked 2026-10-30.
- Generalised anxiety disorder: children and young people — NHS Education for Scotland — The Matrix. Checked 2026-10-30.
- Bipolar disorder — NHS. Checked 2026-10-19.
- Bipolar disorder: assessment and management — recommendations — NICE. Checked 2026-10-17.
- NIMH: Bipolar Disorder — NIMH. Checked 2026-10-19.
- Lifetime and 12-month prevalence of bipolar spectrum disorder: NCS-R — Merikangas and colleagues, Archives of General Psychiatry. Checked 2026-10-16.
- Bipolar disorder: global overview — World Health Organization. Checked 2026-10-16.
- Bipolar disorder research — NIMH. Checked 2026-10-16.
- Bipolar disorder: assessment and management (CG185) — National Institute for Health and Care Excellence. Checked 2026-10-19.
- Schizophrenia: overview — NHS. Checked 2026-10-17.
- Psychosis and schizophrenia in adults: prevention and management — recommendations — NICE. Checked 2026-10-17.
- Schizophrenia — NIMH. Checked 2026-10-16.
- Highlights of Changes from DSM-IV-TR to DSM-5 (2013) — American Psychiatric Association. Checked 2026-10-17.
- Understanding Psychosis — National Institute of Mental Health. Checked 2026-10-17.
- Schizophrenia: global overview — World Health Organization. Checked 2026-10-16.
- Psychosis and schizophrenia in children and young people — recommendations — NICE. Checked 2026-10-30.
- Prescribing guideline for people with a first episode of psychosis — overview — NICE. Checked 2026-10-17.
- Post-traumatic stress disorder (PTSD) — NHS. Checked 2026-10-17.
- Post-traumatic stress disorder, recommendations (NG116) — National Institute for Health and Care Excellence (NICE). Checked 2026-11-04.
- Complex PTSD: Assessment and Treatment — VA National Center for PTSD. Checked 2026-10-17.
- Complex PTSD: History and Definitions — VA National Center for PTSD. Checked 2026-10-17.
- PTSD History and Overview — US Department of Veterans Affairs, National Center for PTSD. Checked 2026-10-17.
- Post-Traumatic Stress Disorder — NIMH. Checked 2026-10-16.
- History of PTSD — VA National Center for PTSD. Checked 2026-10-16.
- Post-Traumatic Stress Disorder: prevalence and methods — NIMH. Checked 2026-10-16.
- PTSD Treatment Basics — VA National Center for PTSD. Checked 2026-10-16.
- Post-traumatic stress disorder (NG116) — recommendations 1.6.18–1.6.20, published 5 December 2018 — National Institute for Health and Care Excellence. Checked 2026-11-14.
- Terminology and Classifications — NHS England. Checked 2026-10-17.
- Mental health: implementing the International Classification of Diseases 11th edition — Scottish Government. Checked 2026-10-17.
- Post-traumatic stress disorder — care for complex needs, section 1.7 — NICE. Checked 2026-10-17.
- Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders (2024) — World Health Organization. Checked 2026-10-17.
- Coping With Traumatic Events — National Institute of Mental Health. Checked 2026-10-17.
- International Trauma Questionnaires (ITQ) — International Trauma Consortium. Checked 2026-10-18.
- Borderline personality disorder: overview — NHS. Checked 2026-10-17.
- Personality disorder ICD-10 terminology — NHS Scotland Right Decisions. Checked 2026-10-17.
- NICE CG78: Borderline personality disorder: recognition and management — NICE CG78. Checked 2026-10-19.
- New manual for mental, behavioural and neurodevelopmental disorders in ICD-11 — World Health Organization. Checked 2026-10-17.
- NIMH: Borderline Personality Disorder — NIMH. Checked 2026-10-19.
- Borderline personality disorder — MedlinePlus Medical Encyclopedia. Checked 2026-10-17.
- Personality disorder — Royal College of Psychiatrists. Checked 2026-10-17.
- Updated Practice Guideline on the Treatment of Borderline Personality Disorder — American Psychiatric Association. Checked 2026-10-17.
- Personality Disorders: NCS-R prevalence and co-occurrence estimates — National Institute of Mental Health. Checked 2026-10-17.
- NHS: Treatment — Borderline personality disorder — NHS. Checked 2026-10-19.
- Guidance for general practice on improving identification of people with a learning disability — NHS England. Checked 2026-10-17.
- Mental health problems in people with learning disabilities: prevention, assessment and management — recommendations — NICE. Checked 2026-10-17.
- What Is Intellectual Disability? — American Psychiatric Association. Checked 2026-10-17.
- About Intellectual and Developmental Disabilities — NICHD. Checked 2026-10-17.
- How are intellectual and developmental disabilities diagnosed? — NICHD. Checked 2026-10-17.
- What should I do if I think my child has an intellectual and developmental disability? — NICHD. Checked 2026-10-17.
- What are the treatments for intellectual and developmental disabilities? — NICHD. Checked 2026-10-17.
- Obsessive compulsive disorder: overview — NHS. Checked 2026-10-17.
- NICE CG31: Obsessive-compulsive disorder and body dysmorphic disorder: treatment — NICE CG31. Checked 2026-10-19.
- Obsessive-Compulsive Disorder — MedlinePlus / National Library of Medicine. Checked 2026-10-17.
- Obsessive-Compulsive and Related Disorders: Excoriation Disorder — American Psychiatric Association. Checked 2026-10-17.
- Obsessive-compulsive disorder — MedlinePlus Genetics. Checked 2026-10-17.
- NIMH: Obsessive-Compulsive Disorder: When Unwanted Thoughts or Repetitive Behaviors Take Over — NIMH. Checked 2026-10-19.
- Obsessive-Compulsive Disorder: NCS-R estimates — NIMH. Checked 2026-10-17.
- Obsessive-compulsive disorder and body dysmorphic disorder: treatment — recommendations — NICE. Checked 2026-10-30.
- Autism — NHS 111 Wales. Checked 2026-10-17.
- What is autism? — NHS. Checked 2026-10-17.
- Autism spectrum disorder in adults: diagnosis and management — recommendations — NICE. Checked 2026-10-17.
- Autism — WHO. Checked 2026-10-17.
- Autism Spectrum Disorder — National Institute of Mental Health. Checked 2026-10-16.
- Screening for Autism Spectrum Disorder — CDC. Checked 2026-10-17.
- Data and Statistics on Autism Spectrum Disorder: 2022 surveillance — CDC. Checked 2026-10-17.
- About Autism Spectrum Disorder — CDC. Checked 2026-10-17.
- Treatment and Intervention for Autism Spectrum Disorder — CDC. Checked 2026-10-17.
- Autism spectrum disorder in under 19s: recognition, referral and diagnosis — recommendations — NICE. Checked 2026-10-17.
- Autism spectrum disorder in under 19s: support and management — recommendations — NICE. Checked 2026-10-30.
- Panic Disorder: When Fear Overwhelms — NIMH. Checked 2026-10-16.
- What Are Anxiety Disorders? — American Psychiatric Association. Checked 2026-10-17.
- Panic disorder: NCS-R and NCS-A survey estimates — NIMH. Checked 2026-10-17.
- Panic disorder — MedlinePlus Medical Encyclopedia. Checked 2026-10-17.
- Anorexia nervosa: Overview — NHS. Checked 2026-10-17.
- Anorexia nervosa: Treatment — NHS. Checked 2026-10-17.
- Eating disorders: recognition and treatment — recommendations — NICE. Checked 2026-10-17.
- What Are Eating Disorders? Other Specified Feeding and Eating Disorder — American Psychiatric Association. Checked 2026-10-17.
- Eating Disorders: What You Need to Know — NIMH. Checked 2026-10-17.
- Eating Disorders: National Comorbidity Survey estimates — NIMH. Checked 2026-10-17.
- Recognizing medical emergencies — MedlinePlus Medical Encyclopedia. Checked 2026-10-17.
- Sudden confusion (delirium) — NHS. Checked 2026-10-21.
- Eating disorders: recognition and treatment (NG69) — NICE. Checked 2026-10-21.
- NHS: alcohol-use disorder — NHS. Checked 2026-10-17.
- NICE CG115: alcohol-use disorders — pharmacological interventions, section 1.3.6 — NICE. Checked 2026-10-17.
- Understanding Alcohol Use Disorder — NIAAA. Checked 2026-10-17.
- Treatment for Alcohol Problems: Finding and Getting Help — NIAAA. Checked 2026-10-17.
- Delirium tremens — MedlinePlus Medical Encyclopedia. Checked 2026-10-17.
- Alcohol Use Disorder in the United States: 2024 NSDUH estimates — NIAAA. Checked 2026-10-17.
- Alcohol and the Brain: An Overview — NIAAA. Checked 2026-10-17.
- UK clinical guidelines for alcohol treatment — chapter 10, pharmacological interventions — Department of Health and Social Care. Checked 2026-10-17.
- Alcohol-use disorders: diagnosis, assessment and management — recommendations — NICE. Checked 2026-10-30.
- Insomnia — NHS. Checked 2026-10-17.
- NICE TA922: Daridorexant for treating long-term insomnia — NICE TA922. Checked 2026-10-19.
- Insomnia: What Is Insomnia? — NHLBI. Checked 2026-10-17.
- Insomnia: Diagnosis — NHLBI. Checked 2026-10-17.
- NHLBI: Insomnia — Treatment — NHLBI. Checked 2026-10-19.
- Insomnia: Causes and Risk Factors — NHLBI. Checked 2026-10-17.
- Insomnia: Living With Insomnia — NHLBI. Checked 2026-10-17.
- Daridorexant for treating long-term insomnia — guidance TA922 — NHS Medicines Awareness Service. Checked 2026-10-17.
- Sleep and young children — NHS. Checked 2026-10-30.
- Creating and maintaining a sleep diary — NHS children’s health service. Checked 2026-10-30.
- About melatonin — NHS. Checked 2026-10-30.
- Behavior or Conduct Problems in Children — CDC. Checked 2026-10-17.
- Antisocial behaviour and conduct disorders in children and young people — recommendations — NICE. Checked 2026-10-30.
- Treating Children's Mental Health with Therapy — CDC. Checked 2026-10-17.
- Children With Oppositional Defiant Disorder — American Academy of Child and Adolescent Psychiatry. Checked 2026-10-16.
- Questions About Oppositional Defiant Disorder — American Academy of Child and Adolescent Psychiatry. Checked 2026-10-16.
- Disruptive Mood Dysregulation Disorder: The Basics — NIMH. Checked 2026-10-17.
- DSM-IV to DSM-5 classification changes: mania and bipolar I — SAMHSA. Checked 2026-10-16.
- NICE CG185: Bipolar disorder — scope — NICE. Checked 2026-10-17.
- DSM-IV to DSM-5 Bipolar II Disorder Comparison — SAMHSA. Checked 2026-10-16.
- Heritable factors in the severity of affective illness (1976) — Dunner, Gershon and Goodwin, Biological Psychiatry. Checked 2026-10-16.
- Get help with anxiety, fear or panic — NHS. Checked 2026-10-17.
- NHS Talking Therapies for anxiety and depression — NHS England. Checked 2026-10-17.
- Any Anxiety Disorder: historical survey scope — NIMH. Checked 2026-10-16.
- Antisocial personality disorder — MedlinePlus Medical Encyclopedia. Checked 2026-10-17.
- Antisocial Personality Disorder (ASPD) — MSD Manual Professional Edition. Checked 2026-10-17.
- NICE CG77: Antisocial personality disorder — recommendations — NICE. Checked 2026-10-17.
- ICD-10 fifth edition: F63.8 Other habit and impulse disorders — NHS England Clinical Classifications Browser. Checked 2026-10-17.
- Antisocial personality disorder is on a continuum with psychopathy — Journal of Personality Disorders. Checked 2026-10-17.
- Narcissistic personality disorder — MedlinePlus Medical Encyclopedia. Checked 2026-10-17.
- Narcissistic Personality Disorder (NPD) — MSD Manual Professional Edition. Checked 2026-10-17.
- What are Personality Disorders? — American Psychiatric Association. Checked 2026-10-17.
- Personality disorders — NHS. Checked 2026-10-17.
- Histrionic personality disorder — MedlinePlus Medical Encyclopedia. Checked 2026-10-17.
- Histrionic Personality Disorder (HPD) — MSD Manual Professional Edition. Checked 2026-10-17.
- Personality Disorders — National Library of Medicine. Checked 2026-10-17.
- NHS England Classifications Browser — NHS England. Checked 2026-10-17.
- ICD-11: mental, behavioural and neurodevelopmental disorders — NHS Education for Scotland. Checked 2026-10-17.
- Paranoid personality disorder — MedlinePlus / A.D.A.M.. Checked 2026-10-17.
- Personality disorder — NHS inform. Checked 2026-10-17.
- Treatment of Paranoid Personality Disorder with Cognitive Analytic Therapy: A Mixed Methods Single Case Experimental Design (2014) — Kellett and Hardy, Clinical Psychology & Psychotherapy. Checked 2026-10-17.
- Prevalence, correlates, and disability of personality disorders in the United States (2004) — Grant and colleagues, Journal of Clinical Psychiatry. Checked 2026-10-17.
- Schizoid personality disorder — MedlinePlus / A.D.A.M.. Checked 2026-10-17.
- Autism Spectrum Disorder — National Institute of Mental Health. Checked 2026-10-17.
- Schizotypal personality disorder — MedlinePlus / A.D.A.M.. Checked 2026-10-17.
- NHS England ICD-10 5th Edition: F20–F29 — NHS England. Checked 2026-10-17.
- Prevalence, correlates, disability, and comorbidity of DSM-IV schizotypal personality disorder: NESARC Wave 2 (2009) — Pulay and colleagues, Primary Care Companion to the Journal of Clinical Psychiatry. Checked 2026-10-17.
- Psychosis and schizophrenia in adults: recommendations — NICE. Checked 2026-10-17.
- Risperidone in the treatment of schizotypal personality disorder (2003) — Koenigsberg and colleagues, Journal of Clinical Psychiatry. Checked 2026-10-17.
- Avoidant personality disorder — MedlinePlus / A.D.A.M.. Checked 2026-10-17.
- Group schema therapy versus group cognitive behavioral therapy for social anxiety disorder with avoidant personality disorder: randomized controlled trial (2024) — Baljé and colleagues, Journal of Anxiety Disorders. Checked 2026-10-17.
- Dependent personality disorder — MedlinePlus / A.D.A.M.. Checked 2026-10-17.
- Results of a Multicenter Randomized Controlled Trial of the Clinical Effectiveness of Schema Therapy for Personality Disorders (2014) — Bamelis and colleagues, American Journal of Psychiatry. Checked 2026-10-17.
- Group schema therapy for cluster-C personality disorders: A multicentre open pilot study (2023) — Wibbelink and colleagues, Clinical Psychology & Psychotherapy. Checked 2026-10-17.
- Obsessive-compulsive personality disorder — MedlinePlus / A.D.A.M.. Checked 2026-10-17.
- Persistent depressive disorder — MedlinePlus. Checked 2026-10-17.
- DSM-5-TR: Persistent Depressive Disorder — American Psychiatric Association. Checked 2026-10-17.
- Clinical descriptions and diagnostic requirements for ICD-11: oppositional defiant disorder with chronic irritability-anger — World Health Organization. Checked 2026-10-17.
- Persistent Depressive Disorder: NCS-R estimates and methods — NIMH. Checked 2026-10-17.
- Cyclothymia — NHS. Checked 2026-10-17.
- Cyclothymic disorder — MedlinePlus. Checked 2026-10-17.
- Premenstrual dysphoric disorder (PMDD) — HHS Office on Women's Health. Checked 2026-10-17.
- Premenstrual dysphoric disorder — MedlinePlus. Checked 2026-10-17.
- PMS and premenstrual dysphoric disorder — NHS. Checked 2026-10-17.
- Premenstrual Dysphoric Disorder: NIMH reproductive mental health research — NIMH. Checked 2026-10-17.
- Sex Hormone-Sensitive Gene Complex Linked to Premenstrual Mood Disorder: archived 2017 report — NIMH. Checked 2026-10-17.
- Managing premenstrual syndrome — Royal College of Obstetricians and Gynaecologists. Checked 2026-10-17.
- Toward the Reliable Diagnosis of DSM-5 Premenstrual Dysphoric Disorder: The Carolina Premenstrual Assessment Scoring System (C-PASS) — American Journal of Psychiatry. Checked 2026-10-21.
- FDA requiring Boxed Warning updated to improve safe use of benzodiazepine drug class — US Food and Drug Administration. Checked 2026-10-17.
- Medicines associated with dependence or withdrawal symptoms — recommendations — NICE. Checked 2026-10-17.
- Corticosteroids: early psychiatric side-effects — MHRA. Checked 2026-10-17.
- DSM-5-TR: Substance/Medication-Induced Bipolar and Related Disorder — American Psychiatric Association. Checked 2026-10-17.
- Understanding the Link Between Chronic Disease and Depression — National Institute of Mental Health. Checked 2026-10-17.
- Hypothyroidism (Underactive Thyroid) — NIDDK. Checked 2026-10-17.
- NICE CG91: Depression with a chronic physical health problem — NICE. Checked 2026-10-17.
- DSM-5-TR: Depressive Disorder Due to Another Medical Condition — American Psychiatric Association. Checked 2026-10-17.
- DSM-5-TR: Bipolar and Related Disorder Due to Another Medical Condition — American Psychiatric Association. Checked 2026-10-17.
- Hyperthyroidism (Overactive Thyroid) — NIDDK. Checked 2026-10-17.
- Agoraphobia: overview — NHS. Checked 2026-10-17.
- Agoraphobia — MedlinePlus Medical Encyclopedia. Checked 2026-10-17.
- Agoraphobia: diagnosis — NHS. Checked 2026-10-17.
- Agoraphobia: treatment — NHS. Checked 2026-10-17.
- Agoraphobia: NCS-R and NCS-A survey estimates — NIMH. Checked 2026-10-17.
- Social Anxiety Disorder: What You Need to Know — NIMH. Checked 2026-10-17.
- Anxiety and Depression in Children — CDC. Checked 2026-10-17.
- Social anxiety (social phobia) — NHS. Checked 2026-10-17.
- NICE CG159: Social anxiety disorder — recommendations — NICE. Checked 2026-10-17.
- Social anxiety disorder: NCS-R and NCS-A survey estimates — NIMH. Checked 2026-10-17.
- Social anxiety disorder: recognition, assessment and treatment (CG159) — NICE. Checked 2026-10-21.
- Phobias — NHS. Checked 2026-10-17.
- Phobia: simple/specific — MedlinePlus Medical Encyclopedia. Checked 2026-10-17.
- Specific phobia: NCS-R and NCS-A survey estimates — NIMH. Checked 2026-10-17.
- Selective mutism — MedlinePlus Medical Encyclopedia. Checked 2026-10-17.
- Selective Mutism — Communication Health Support Association; ASHA-linked public information. Checked 2026-10-17.
- Selective mutism — NHS. Checked 2026-10-30.
- Selective Mutism: Practice Portal — American Speech-Language-Hearing Association. Checked 2026-10-17.
- A randomized controlled trial of a home and school-based intervention for selective mutism (2014): publication record — Oerbeck and colleagues; NKVTS publication record. Checked 2026-10-17.
- What Is Schizophrenia? Related Conditions (2024-03) — American Psychiatric Association. Checked 2026-10-17.
- Schizoaffective disorder — MedlinePlus Medical Encyclopedia. Checked 2026-10-17.
- Schizoaffective disorder — MedlinePlus Genetics. Checked 2026-10-17.
- NIMH: Mental Health Medications — Official labeling / National Library of Medicine. Checked 2026-10-16.
- NHS National Psychosis Service: outpatient scope — South London and Maudsley NHS Foundation Trust. Checked 2026-10-17.
- Psychosis — MedlinePlus Medical Encyclopedia. Checked 2026-10-17.
- Recovery After an Initial Schizophrenia Episode (RAISE) — National Institute of Mental Health. Checked 2026-10-17.
- Brief psychotic disorder — MedlinePlus Medical Encyclopedia. Checked 2026-10-17.
- Psychosis: treatment — NHS. Checked 2026-10-17.
- Psychosis: causes — NHS. Checked 2026-10-17.
- Delirium — MedlinePlus. Checked 2026-10-17.
- Evidence-based consensus guidelines for the management of catatonia (2023) — British Association for Psychopharmacology. Checked 2026-10-17.
- Catatonia — Royal College of Psychiatrists. Checked 2026-10-17.
- Catatonia: information for patients and carers — University College London. Checked 2026-10-17.
- Delirium — MedlinePlus Medical Encyclopedia. Checked 2026-10-17.
- Delirium: Cancer Treatment Side Effect — National Cancer Institute. Checked 2026-10-17.
- Delirium: prevention, diagnosis and management in hospital and long-term care — Recommendations (CG103) — NICE. Checked 2026-10-18.
- Delirium: prevention, diagnosis and management in hospital and long-term care — Overview (CG103) — NICE. Checked 2026-10-18.
- Using, reproducing and adapting the 4AT — 4AT developers. Checked 2026-10-18.
- What Are Dissociative Disorders? — American Psychiatric Association. Checked 2026-10-17.
- Dissociative disorders — NHS. Checked 2026-10-19.
- Guidelines for Treating Dissociative Identity Disorder in Adults, Third Revision (2011) — International Society for the Study of Trauma and Dissociation. Checked 2026-10-17.
- Fact Sheet IV: What Are the Dissociative Disorders? — International Society for the Study of Trauma and Dissociation. Checked 2026-10-17.
- Fact Sheet V: Getting Treatment for Complex Trauma and Dissociation — International Society for the Study of Trauma and Dissociation. Checked 2026-10-17.
- ICD-10 5th Edition: F40–F48 — NHS England classifications browser. Checked 2026-10-17.
- What is Functional Neurological Disorder? — Worcestershire Acute Hospitals NHS Trust. Checked 2026-10-17.
- Functional Neurological Symptoms — Gloucestershire Hospitals NHS Foundation Trust. Checked 2026-10-17.
- Functional Neurological Disorder: Physiotherapy — St George's University Hospitals NHS Foundation Trust. Checked 2026-10-17.
- Functional Neurological Disorder — University Hospitals Plymouth NHS Trust. Checked 2026-10-17.
- Symptoms of a stroke — NHS. Checked 2026-10-17.
- Acute Stress Disorder: assessment and treatment — VA National Center for PTSD. Checked 2026-10-17.
- Acute Stress Disorder — VA National Center for PTSD. Checked 2026-10-17.
- Adjustment disorder — MedlinePlus Medical Encyclopedia. Checked 2026-10-17.
- Adjustment Disorders — MSD Manual Professional Edition. Checked 2026-10-17.
- Adjusting to difficult life events — Camden and Islington NHS Talking Therapies. Checked 2026-10-17.
- Prolonged Grief Disorder — American Psychiatric Association. Checked 2026-10-17.
- Grief, Bereavement, and Loss (PDQ): Patient Version — National Cancer Institute. Checked 2026-10-17.
- Get help with grief after bereavement or loss — NHS. Checked 2026-10-17.
- Prolonged grief disorder therapy — Devon Partnership NHS Trust TALKWORKS. Checked 2026-10-17.
- Prolonged grief disorder: DSM-5-TR fact sheet — American Psychiatric Association. Checked 2026-10-17.
- Attachment Disorders: Facts for Families — American Academy of Child and Adolescent Psychiatry. Checked 2026-10-17.
- Policy Statement on Coercive Interventions for Attachment Disorders — American Academy of Child and Adolescent Psychiatry. Checked 2026-10-17.
- NICE NG26: Children's attachment recommendations — NICE. Checked 2026-10-17.
- A randomized controlled trial comparing foster care and institutional care for children with signs of reactive attachment disorder — Smyke and colleagues, American Journal of Psychiatry (2012). Checked 2026-10-17.
- NICE QS133: Video feedback programmes — NICE. Checked 2026-10-17.
- Children’s attachment — recommendations — NICE. Checked 2026-10-30.
- Dissociative Amnesia — MSD Manual Professional Edition. Checked 2026-10-17.
- Body dysmorphic disorder — NHS. Checked 2026-10-17.
- Hoarding disorder — NHS. Checked 2026-10-17.
- What is Hoarding Disorder? — American Psychiatric Association. Checked 2026-10-17.
- Hoarding disorder: assessment and CBT — Oxford Health NHS Foundation Trust. Checked 2026-10-17.
- Trichotillomania (hair pulling disorder) — NHS. Checked 2026-10-17.
- Skin picking disorder — NHS. Checked 2026-10-17.
- Health anxiety — NHS. Checked 2026-10-17.
- What is Somatic Symptom Disorder? — American Psychiatric Association. Checked 2026-10-17.
- Illness anxiety disorder — MedlinePlus, US National Library of Medicine. Checked 2026-10-17.
- Somatic symptom disorder — MedlinePlus, US National Library of Medicine. Checked 2026-10-17.
- Medically unexplained symptoms — NHS. Checked 2026-10-17.
- Munchausen syndrome: overview — NHS. Checked 2026-10-17.
- Perplexing Presentations / Fabricated or Induced Illness in children: guidance (2021, updated document) — Royal College of Paediatrics and Child Health. Checked 2026-10-17.
- Fabricated or induced illness: overview — NHS. Checked 2026-10-17.
- Diabetes Distress and Depression (January 8, 2020) — National Institute of Diabetes and Digestive and Kidney Diseases. Checked 2026-10-17.
- Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence (CG76) — National Institute for Health and Care Excellence. Checked 2026-10-17.
- Highlights of Changes from DSM-IV to DSM-5: Somatic Symptom and Related Disorders (2013) — American Psychiatric Association Division of Research. Checked 2026-10-17.
- ICD-10 5th Edition: F54 — NHS England classifications browser. Checked 2026-10-17.
- Psychological medicine support — West London NHS Trust. Checked 2026-10-17.
- Developmental Language Disorder — NIDCD. Checked 2026-10-17.
- Speech and Language Developmental Milestones — NIDCD. Checked 2026-10-17.
- Stuttering — NIDCD. Checked 2026-10-17.
- Speech Sound Disorders: Articulation and Phonology — American Speech-Language-Hearing Association. Checked 2026-10-17.
- Social Communication Disorder — American Speech-Language-Hearing Association. Checked 2026-10-17.
- Developmental language disorder — Newcastle Hospitals NHS Foundation Trust. Checked 2026-10-17.
- Stammering: treatment — NHS. Checked 2026-10-17.
- NIDCD History and Milestones — NIDCD. Checked 2026-10-17.
- What Are Specific Learning Disorders? — American Psychiatric Association. Checked 2026-10-17.
- About Learning Disabilities — NICHD. Checked 2026-10-17.
- What are some signs of learning disabilities? — NICHD. Checked 2026-10-17.
- How are learning disabilities diagnosed? — NICHD. Checked 2026-10-17.
- What are the treatments for learning disabilities? — NICHD. Checked 2026-10-17.
- Dyslexia in children — NHS. Checked 2026-10-17.
- Dyslexia in adults — NHS. Checked 2026-10-17.
- Specific Learning Difficulties: Dyscalculia, Dyslexia and Dysgraphia — Just One Norfolk NHS. Checked 2026-10-17.
- Find out more about the Learning Disability Register — NHS England. Checked 2026-10-17.
- Developmental co-ordination disorder in children: Overview — NHS. Checked 2026-10-17.
- Developmental co-ordination disorder in children: Symptoms — NHS. Checked 2026-10-17.
- DCD in children: diagnosis — NHS. Checked 2026-10-17.
- Developmental co-ordination disorder in children: treatment — NHS. Checked 2026-10-30.
- Dyspraxia in adults — NHS. Checked 2026-10-17.
- Stereotypic movement disorder — MedlinePlus Medical Encyclopedia. Checked 2026-10-17.
- Motor Stereotypies — Johns Hopkins Medicine. Checked 2026-10-17.
- Stereotypies: repetitive movements or sounds — Great Ormond Street Hospital. Checked 2026-10-17.
- Understanding Motor Stereotypies as a Transdiagnostic Phenotype (2025) — Journal of the American Academy of Child and Adolescent Psychiatry. Checked 2026-10-17.
- Stereotypic Movement Disorder — Cleveland Clinic. Checked 2026-10-17.
- About Tourette Syndrome — CDC. Checked 2026-10-17.
- Diagnosing Tic Disorders — CDC. Checked 2026-10-17.
- Treatment of Tourette Syndrome — CDC. Checked 2026-10-17.
- Data and Statistics on Tourette Syndrome — CDC. Checked 2026-10-17.
- Tourette Syndrome — NIH. Checked 2026-10-17.
- Information about Tourette Syndrome for Educators — CDC. Checked 2026-10-17.
- Tourette syndrome — NHS. Checked 2026-10-30.
- Tic disorders and Tourette Syndrome — Oxford Health NHS Foundation Trust. Checked 2026-10-17.
- What are Disruptive, Impulse Control and Conduct Disorders? — American Psychiatric Association. Checked 2026-10-17.
- Conduct Disorder Resource Center — American Academy of Child and Adolescent Psychiatry. Checked 2026-10-17.
- Conduct disorder — MedlinePlus Medical Encyclopedia. Checked 2026-10-17.
- NICE QS59: Monitoring adverse effects — NICE. Checked 2026-10-17.
- Risperidone 0.5 mg tablets — UK SmPC — Marketing authorisation holder / eMC. Checked 2026-10-30.
- Signs and Symptoms of Stroke — CDC. Checked 2026-10-17.
- What Is Mild Cognitive Impairment? — National Institute on Aging. Checked 2026-10-17.
- Cognitive Testing — MedlinePlus. Checked 2026-10-17.
- A Well-Aged Mind: Maintaining Your Cognitive Health — NIH News in Health. Checked 2026-10-17.
- Mild Cognitive Impairment (MCI) – Patient Information Leaflet — Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust. Checked 2026-10-17.
- How to get a dementia diagnosis — NHS. Checked 2026-10-17.
- Lecanemab licensed for adult patients in the early stages of Alzheimer's disease — MHRA. Checked 2026-10-17.
- Lecanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease [ID4043]: project information — NICE. Checked 2026-10-17.
- Dementia: fact sheet, 3 July 2026 — World Health Organization. Checked 2026-10-17.
- Dementia — MedlinePlus. Checked 2026-10-17.
- What are the treatments for dementia? — NHS. Checked 2026-10-17.
- Alzheimer's Disease Fact Sheet — National Institute on Aging. Checked 2026-10-17.
- Alzheimer's Disease — MedlinePlus. Checked 2026-10-17.
- Alzheimer's disease: diagnosis — NHS. Checked 2026-10-17.
- Alzheimer's disease: treatment — NHS. Checked 2026-10-17.
- Donanemab licensed for early stages of Alzheimer's disease in adult patients who have one or no copies of apolipoprotein E4 gene — MHRA. Checked 2026-10-17.
- Donanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease [ID6222]: project information — NICE. Checked 2026-10-17.
- Vascular Dementia: Causes, Symptoms, and Treatments — National Institute on Aging. Checked 2026-10-17.
- Vascular dementia — NHS. Checked 2026-10-17.
- Vascular dementia: treatment — NHS. Checked 2026-10-17.
- Lewy Body Dementia — MedlinePlus, National Library of Medicine. Checked 2026-10-17.
- Dementia with Lewy bodies — MedlinePlus Genetics, National Library of Medicine. Checked 2026-10-17.
- Caring for a Person With Lewy Body Dementia — National Institute on Aging. Checked 2026-10-17.
- Dementia with Lewy bodies: treatment — NHS. Checked 2026-10-17.
- Dementia with Lewy bodies — NHS. Checked 2026-10-17.
- Dementia: assessment, management and support for people living with dementia and their carers — recommendations (NG97) — NICE. Checked 2026-10-17.
- What Are Frontotemporal Disorders? Causes, Symptoms, and Treatment — National Institute on Aging. Checked 2026-10-17.
- Frontotemporal dementia — MedlinePlus Medical Encyclopedia. Checked 2026-10-17.
- Frontotemporal dementia — NHS. Checked 2026-10-17.
- Frontotemporal dementia: treatment — NHS. Checked 2026-10-17.
- Signs and Symptoms of Mild TBI and Concussion — CDC. Checked 2026-10-17.
- What to Do After a Mild TBI or Concussion — CDC. Checked 2026-10-17.
- About Repeated Head Impacts — CDC. Checked 2026-10-17.
- Traumatic Brain Injury Clinic — University College London Hospitals NHS Foundation Trust. Checked 2026-10-17.
- Nottingham Traumatic Brain Injury Service — Nottingham University Hospitals NHS Trust. Checked 2026-10-17.
- Head injury: assessment and early management — recommendations (NG232) — NICE. Checked 2026-10-17.
- Headaches after traumatic brain injury — patient information leaflet — Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust. Checked 2026-10-17.
- Parkinson disease — MedlinePlus Genetics, National Library of Medicine. Checked 2026-10-17.
- Parkinson's disease in adults — recommendations (NG71) — NICE. Checked 2026-10-17.
- ICD-10 fifth edition: F00–F09 — NHS England. Checked 2026-10-17.
- Lustral 100 mg: UK SmPC — Viatris Products Limited / emc. Checked 2026-10-17.
- What Is a Neurotransmitter? — NIH — NIGMS. Checked 2026-10-16.
- Efexor XL 75 mg: UK SmPC — Viatris / emc. Checked 2026-10-17.
- Lamictal tablets and chewable/dispersible tablets — UK SmPC — The Wellcome Foundation Ltd, trading as GlaxoSmithKline UK. Checked 2026-10-17.
- Sodium-channel states in rat nerve-cell experiments by Kuo and Lu — Original research indexed by the National Library of Medicine. Checked 2026-10-16.
- Abilify 30 mg tablets — UK SmPC — Otsuka Pharmaceutical Netherlands B.V.. Checked 2026-10-17.
- Shapiro and colleagues: aripiprazole in cloned receptor systems — Official labeling / National Library of Medicine. Checked 2026-10-17.
- Priadel 400 mg prolonged-release tablets — UK SmPC — Essential Pharma Limited. Checked 2026-10-17.
- Hallcher and Sherman: Effects of lithium on myo-inositol-1-phosphatase from bovine brain — mechanism explanation — National Library of Medicine / PubMed. Checked 2026-10-24.
- Zhang and colleagues: Inhibitory phosphorylation of GSK-3 in response to lithium — mechanism explanation — National Library of Medicine / PubMed. Checked 2026-10-24.
- Concerta XL 54 mg prolonged-release tablets — UK SmPC — Janssen-Cilag Limited. Checked 2026-10-17.
- Easton and colleagues: comparison of stimulant effects in rat preparations — Official labeling / National Library of Medicine. Checked 2026-10-17.
- Elvanse 30 mg capsules — UK SmPC — Takeda UK Limited. Checked 2026-10-17.
- Intuniv 1 mg prolonged-release tablets: SmPC, sections 4–5 — Takeda / electronic medicines compendium. Checked 2026-10-17.
- Xanax 500 microgram tablets: SmPC — Viatris Products Limited / emc. Checked 2026-10-17.
- Zyban 150 mg: UK SmPC — GlaxoSmithKline / emc. Checked 2026-10-17.
- Ebixa 10 mg film-coated tablets: SmPC — H. Lundbeck A/S / emc. Checked 2026-10-17.
- NHS: Memantine — NHS. Checked 2026-10-17.
- Aricept 5 mg film-coated tablets: SmPC — Eisai Ltd / emc. Checked 2026-10-17.
- Cipralex: UK adult licence for comparison — Lundbeck / emc. Checked 2026-10-17.
- Escitalopram (PubChem CID 146570) — NIH National Library of Medicine — PubChem. Checked 2026-10-17.
- Seroquel film-coated tablets — UK SmPC — Luye Pharma Limited. Checked 2026-10-17.
- Off-label or unlicensed use of medicines: prescribers’ responsibilities — Medicines and Healthcare products Regulatory Agency. Checked 2026-10-17.
- Differential Diagnosis — National Library of Medicine — MedlinePlus. Checked 2026-10-21.
- What to expect of your psychiatrist in the UK — Royal College of Psychiatrists. Checked 2026-10-21.
- Mental health assessments (including second opinions) — National Health Service (NHS). Checked 2026-10-21.
- Mental Health Screening — National Library of Medicine — MedlinePlus. Checked 2026-10-21.
- NHS Talking Therapies: service standards — NHS England. Checked 2026-10-17.
- Patient Health Questionnaire (PHQ) Screeners. Free Download — PHQ Screeners / Pfizer. Checked 2026-10-18.
- Instruction Manual: Instructions for Patient Health Questionnaire (PHQ) and GAD-7 Measures — PHQ Screeners. Checked 2026-10-18.
- Standards of proficiency: practitioner psychologists — Health and Care Professions Council. Checked 2026-10-17.
- A brief guide to your neuropsychological assessment — Cambridge University Hospitals NHS Foundation Trust. Checked 2026-10-21.
- What is the DSM? — American Psychiatric Association. Checked 2026-10-17.
- Updates to DSM Criteria, Text and ICD-10 Codes — American Psychiatric Association. Checked 2026-10-17.
- DSM History — American Psychiatric Association. Checked 2026-10-17.
- ICD-10 — Digital Health and Care Wales. Checked 2026-10-17.
- Assessing your mental health needs – children and young people — National Health Service (NHS). Checked 2026-10-21.
- Mental health services and support — nidirect. Checked 2026-10-17.
- Understanding ADHD — NHS Dorset. Checked 2026-10-17.
- Bipolar disorder – Caring for our carers — Oxford Health NHS Foundation Trust. Checked 2026-10-17.
- About Autism — NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development. Checked 2026-10-17.
- NHS: Talking therapies — NHS. Checked 2026-10-19.
- Depression in adults: treatment and management (NG222) — National Institute for Health and Care Excellence (NICE). Checked 2026-10-21.
- Depression Screening — National Library of Medicine — MedlinePlus. Checked 2026-10-21.
- Tips for Talking With a Health Care Provider About Your Mental Health — National Institute of Mental Health (NIMH). Checked 2026-10-21.
- The seven principles of decision making and consent — General Medical Council (GMC). Checked 2026-10-21.
- Ethical and legal duties of confidentiality — General Medical Council (GMC). Checked 2026-10-21.
- Confidentiality: using and disclosing information for secondary purposes — General Medical Council (GMC). Checked 2026-10-21.
- Managing and protecting personal information — General Medical Council (GMC). Checked 2026-10-21.
- General practice services — NHS inform. Checked 2026-10-17.
- Mental Health — Cardiff and Vale University Health Board. Checked 2026-10-17.
- Where to get urgent help for mental health — NHS. Checked 2026-10-17.
- Get urgent mental health help — NHS inform / NHS 24. Checked 2026-10-21.
- NHS 111 Press 2 — Welsh Government. Checked 2026-10-17.
- Psychosis: diagnosis — National Health Service (NHS). Checked 2026-10-21.
- About DSM-5-TR — American Psychiatric Association. Checked 2026-10-17.
- Buspirone Hydrochloride 5 mg tablets: UK SmPC — mechanism explanation — Generics (UK) Limited trading as Viatris / electronic medicines compendium. Checked 2026-10-24.
- Buspirone Hydrochloride 10 mg tablets: SmPC — Generics (UK) Limited trading as Viatris / emc. Checked 2026-10-17.
- Buspirone Hydrochloride 7.5 mg tablets: SmPC — Strides Pharma UK Ltd / emc. Checked 2026-10-17.
- Buspirone Hydrochloride 5 mg and 10 mg tablets: patient leaflet — Viatris / emc. Checked 2026-10-17.
- Buspirone hydrochloride 7.5 mg tablets: patient leaflet — Strides Pharma UK Ltd / emc. Checked 2026-10-17.
- Buspirone hydrochloride tablets prescribing information — mechanism explanation — National Library of Medicine, DailyMed. Checked 2026-10-24.
- Aricept Evess 10 mg orodispersible tablets: SmPC — Eisai Ltd / emc. Checked 2026-10-17.
- NHS: About donepezil — NHS. Checked 2026-10-17.
- NHS: How and when to take donepezil — NHS. Checked 2026-10-17.
- NHS: Side effects of donepezil — NHS. Checked 2026-10-17.
- NHS: Taking donepezil with other medicines and herbal supplements — NHS. Checked 2026-10-17.
- NHS: Pregnancy, breastfeeding and fertility while taking donepezil — NHS. Checked 2026-10-17.
- Acetylcholinesterase inhibitors monitoring — NHS Specialist Pharmacy Service. Checked 2026-10-17.
- NICE NG97: Dementia recommendations — NICE. Checked 2026-10-17.
- NICE TA217: What has NICE said? — NICE. Checked 2026-10-17.
- Aricept (donepezil): prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Donepezil: MedlinePlus Drug Information — mechanism explanation — US National Library of Medicine / MedlinePlus; American Society of Health-System Pharmacists. Checked 2026-10-24.
- Exelon 4.6, 9.5 and 13.3 mg/24 h patches: SmPC — Novartis Pharmaceuticals UK Ltd / emc. Checked 2026-10-17.
- Rivastigmine Sandoz 1.5 mg hard capsules: SmPC — Sandoz Limited / emc. Checked 2026-10-17.
- Rivastigmine Sandoz 2 mg/ml oral solution: Summary of Product Characteristics — mechanism explanation — Sandoz Limited / electronic medicines compendium. Checked 2026-10-24.
- Exelon transdermal patches: patient leaflet — Novartis Pharmaceuticals UK Ltd / emc. Checked 2026-10-17.
- Rivastigmine (Exelon) transdermal patch: risk of medication errors — MHRA. Checked 2026-10-17.
- Exelon Patch (rivastigmine): prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Rivastigmine tartrate capsules: prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Rivastigmine: MedlinePlus Drug Information — mechanism explanation — US National Library of Medicine / MedlinePlus; American Society of Health-System Pharmacists. Checked 2026-10-24.
- Gatalin XL 8 mg prolonged-release capsules: SmPC — Aspire Pharma Ltd / emc. Checked 2026-10-17.
- Galantamine 4 mg/ml oral solution: SmPC — Syri Limited trading as SyriMed / emc. Checked 2026-10-17.
- Gatalin XL 8 mg, 16 mg and 24 mg capsules: patient leaflet — Aspire Pharma Ltd / emc. Checked 2026-10-17.
- Drugs for dementia: galantamine, information for primary care — NHS Greater Manchester Medicines Management Group. Checked 2026-10-17.
- Galantamine immediate-release tablets: prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Galantamine hydrobromide extended-release capsules: prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Zunveyl (benzgalantamine): prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Galantamine: MedlinePlus Drug Information — mechanism explanation — US National Library of Medicine / MedlinePlus; American Society of Health-System Pharmacists. Checked 2026-10-24.
- Ebixa 5 mg/pump actuation oral solution: SmPC — H. Lundbeck A/S / emc. Checked 2026-10-17.
- Ebixa 5 mg/pump actuation oral solution: patient leaflet — Lundbeck / emc. Checked 2026-10-17.
- Memantine hydrochloride immediate-release tablets: prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Memantine hydrochloride extended-release capsules: prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Memantine: MedlinePlus Drug Information — mechanism explanation — US National Library of Medicine / MedlinePlus; American Society of Health-System Pharmacists. Checked 2026-10-24.
- Xanax 250 microgram tablets: SmPC — Viatris Products Limited / emc. Checked 2026-10-17.
- Xanax 250 and 500 microgram tablets: patient leaflet — Viatris / emc. Checked 2026-10-17.
- Strengthened information on dependence, addiction, withdrawal and tolerance — benzodiazepines, Z-drugs and gabapentinoids — MHRA. Checked 2026-10-17.
- NICE CG113: What treatments should I be offered for panic disorder? — NICE. Checked 2026-10-17.
- Xanax: UK product information and supply notice — Viatris / emc. Checked 2026-10-17.
- Benzodiazepines: medicines and risks of addiction, dependence and withdrawal — MHRA. Checked 2026-10-17.
- Xanax immediate-release: current prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Alprazolam: MedlinePlus Drug Information — mechanism explanation — US National Library of Medicine / MedlinePlus. Checked 2026-10-24.
- Intermittent explosive disorder subtypes in the general population: association with comorbidity, impairment and suicidality — Scott and colleagues / Epidemiology and Psychiatric Sciences. Checked 2026-10-17.
- Intermittent Explosive Disorder and aversive parental care — Psychiatry Research / PubMed. Checked 2026-10-17.
- Amygdala hyperactivation to angry faces in intermittent explosive disorder — Journal of Psychiatric Research / PubMed. Checked 2026-10-17.
- Cognitive-behavioral therapy for intermittent explosive disorder: a pilot randomized clinical trial — McCloskey and colleagues / Journal of Consulting and Clinical Psychology; PubMed. Checked 2026-10-17.
- Cognitive-Behavioral Versus Supportive Psychotherapy for Intermittent Explosive Disorder: A Randomized Controlled Trial — McCloskey and colleagues / Behavior Therapy; PubMed. Checked 2026-10-17.
- A Double-Blind, Randomized, Placebo-Controlled Trial of Fluoxetine in Patients With Intermittent Explosive Disorder — Coccaro, Kavoussi and Lee / The Journal of Clinical Psychiatry. Checked 2026-10-17.
- Get help with anger — NHS. Checked 2026-10-17.
- Domestic abuse: how to get help — UK Government. Checked 2026-10-17.
- When to call 999 — NHS. Checked 2026-10-17.
- Opioids and Opioid Use Disorder (OUD) — MedlinePlus. Checked 2026-10-17.
- What Is a Substance Use Disorder? (physician review 2024-04) — American Psychiatric Association. Checked 2026-10-17.
- Opioid addiction — MedlinePlus Genetics. Checked 2026-10-17.
- Heroin addiction: get help — NHS. Checked 2026-10-17.
- Drug addiction: getting help — NHS. Checked 2026-10-17.
- Drug misuse in over 16s: psychosocial interventions — recommendations — NICE. Checked 2026-10-17.
- What you need to know about taking drugs — NHS inform / Public Health Scotland. Checked 2026-10-17.
- Opioid overdose — World Health Organization. Checked 2026-10-17.
- Opioid Use Disorder (OUD) Treatment — MedlinePlus. Checked 2026-10-17.
- Cannabis — MedlinePlus. Checked 2026-10-17.
- Understanding Your Risk for Cannabis Use Disorder — Centers for Disease Control and Prevention. Checked 2026-10-17.
- Cannabis: effects and risks — FRANK. Checked 2026-10-17.
- Cannabis — NHS inform. Checked 2026-10-17.
- Cannabis and Mental Health — Centers for Disease Control and Prevention. Checked 2026-10-17.
- ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder — American Society of Addiction Medicine and American Academy of Addiction Psychiatry. Checked 2026-10-17.
- Cocaine addiction: get help — NHS. Checked 2026-10-17.
- Cocaine — NHS inform. Checked 2026-10-17.
- Joint Clinical Practice Guideline on Benzodiazepine Tapering (2025) — American Society of Addiction Medicine and partner professional societies. Checked 2026-10-17.
- NG215: rationale and impact — NICE. Checked 2026-10-17.
- The Relative Risks of Tobacco Products — US Food and Drug Administration. Checked 2026-10-17.
- Want to Quit Smoking? FDA-Approved and FDA-Cleared Cessation Products Can Help — US Food and Drug Administration. Checked 2026-10-17.
- Managing nicotine withdrawal symptoms — NHS Better Health. Checked 2026-10-17.
- Tobacco: treating dependence — NICE. Checked 2026-10-17.
- Tobacco dependence during pregnancy and after childbirth — NICE. Checked 2026-10-17.
- The truth about smoking, stress and mental health — NHS Better Health. Checked 2026-10-17.
- Tobacco: treating tobacco dependence — NICE. Checked 2026-10-30.
- Psilocybin for Mental Health and Addiction: What You Need To Know — National Center for Complementary and Integrative Health. Checked 2026-10-17.
- Substance use — LSD — MedlinePlus Medical Encyclopedia. Checked 2026-10-17.
- Substance use — phencyclidine (PCP) — MedlinePlus Medical Encyclopedia. Checked 2026-10-17.
- LSD: effects and risks — FRANK. Checked 2026-10-17.
- Psilocybin and psilocin: effects and risks — FRANK. Checked 2026-10-17.
- Know When to Go to the ER — American College of Emergency Physicians. Checked 2026-10-17.
- Inhalants — MedlinePlus. Checked 2026-10-17.
- Substance use — inhalants — MedlinePlus Medical Encyclopedia. Checked 2026-10-17.
- Glues, gases and aerosols: effects and risks — FRANK. Checked 2026-10-17.
- Advice for parents and carers — FRANK. Checked 2026-10-17.
- What Is Gambling Disorder? — American Psychiatric Association. Checked 2026-10-17.
- Gambling — World Health Organization. Checked 2026-10-17.
- Help for problems with gambling — NHS. Checked 2026-10-17.
- Gambling-related harms: identification, assessment and management — recommendations — NICE. Checked 2026-10-17.
- Pharmacological treatment of harmful gambling: evidence review E — NICE. Checked 2026-10-17.
- Gambling-related harms: guideline scope — NICE. Checked 2026-10-30.
- Bulimia nervosa — Office on Women's Health, US Department of Health and Human Services. Checked 2026-10-17.
- Bulimia — NHS. Checked 2026-10-17.
- Vomiting blood — NHS. Checked 2026-10-17.
- Definition and Facts for Binge Eating Disorder — NIDDK. Checked 2026-10-17.
- Symptoms and Causes of Binge Eating Disorder — NIDDK. Checked 2026-10-17.
- Binge eating disorder: overview — NHS. Checked 2026-10-17.
- Binge eating disorder: treatment — NHS. Checked 2026-10-17.
- Feeding and Eating Disorders: DSM-5 changes (2013) — American Psychiatric Association. Checked 2026-10-17.
- Diagnosis and Treatment of Binge Eating Disorder — NIDDK. Checked 2026-10-17.
- ARFID in Children and Young People — Humber Teaching NHS Foundation Trust. Checked 2026-10-17.
- Eating Disorders: Overview — NHS. Checked 2026-10-17.
- ARFID clinic — South London and Maudsley NHS Foundation Trust. Checked 2026-10-17.
- Avoidant restrictive food intake disorder: assessment and treatment criteria — Forward Thinking Birmingham. Checked 2026-10-17.
- ARFID: creating your own ideal supportive mealtime — Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust. Checked 2026-10-17.
- Pica — MedlinePlus Medical Encyclopedia. Checked 2026-10-17.
- Lead Exposure Symptoms and Complications — CDC. Checked 2026-10-17.
- Pica (eating non-edible items) — Cambridgeshire and Peterborough Children's Health / NHS. Checked 2026-10-17.
- Poisoning — NHS. Checked 2026-10-17.
- Pica, Autism, and Other Disabilities (2021) — Fields and colleagues; Pediatrics; CDC public-access record. Checked 2026-10-17.
- Button batteries: using them safely — Great Ormond Street Hospital for Children NHS Foundation Trust. Checked 2026-10-21.
- Rumination disorder — MedlinePlus Medical Encyclopedia. Checked 2026-10-17.
- European Guideline on Chronic Nausea and Vomiting: UEG and ESNM Consensus (2025) — Malagelada and colleagues; United European Gastroenterology Journal. Checked 2026-10-17.
- Rumination Syndrome — M8779 — Sandwell and West Birmingham NHS Trust. Checked 2026-10-17.
- Diarrhoea and vomiting: when to seek urgent help — NHS. Checked 2026-10-17.
- Other specified feeding and eating disorder (OSFED) — Berkshire Healthcare NHS Foundation Trust. Checked 2026-10-17.
- DSM-5-TR Update, September 2025: OSFED terminology clarification — American Psychiatric Association. Checked 2026-10-17.
- What Are Sleep Disorders? Hypersomnolence Disorder — American Psychiatric Association. Checked 2026-10-17.
- Idiopathic hypersomnia — MedlinePlus Medical Encyclopedia. Checked 2026-10-17.
- Diagnosis, classification, symptoms, and causes of hypersomnias — Hypersomnia Foundation. Checked 2026-10-17.
- Excessive daytime sleepiness (hypersomnia) — NHS. Checked 2026-10-17.
- Excessive sleepiness and driving — DVLA / GOV.UK. Checked 2026-10-17.
- Idiopathic hypersomnia: diagnosis and treatment on the NHS — Royal Papworth Hospital NHS Foundation Trust. Checked 2026-10-17.
- Narcolepsy — nidirect / Northern Ireland government. Checked 2026-10-17.
- Narcolepsy — NHLBI. Checked 2026-10-17.
- Narcolepsy — MedlinePlus Genetics. Checked 2026-10-17.
- Narcolepsy — NHS. Checked 2026-10-17.
- Narcolepsy — Royal Papworth Hospital NHS Foundation Trust. Checked 2026-10-17.
- Sexual Problems in Women — MedlinePlus, US National Library of Medicine. Checked 2026-10-17.
- Sexual Problems in Men — MedlinePlus, US National Library of Medicine. Checked 2026-10-17.
- Diabetes, Sexual, and Bladder Problems — National Institute of Diabetes and Digestive and Kidney Diseases. Checked 2026-10-17.
- Erectile dysfunction (impotence) — NHS. Checked 2026-10-17.
- Ejaculation problems — NHS. Checked 2026-10-17.
- Vaginismus — NHS. Checked 2026-10-17.
- Low sex drive (loss of libido) — NHS. Checked 2026-10-17.
- Paraphilic Disorders: DSM-5 fact sheet (2013) — American Psychiatric Association. Checked 2026-10-17.
- WFSBP 2020 guidelines for the pharmacological treatment of paraphilic disorders — World Federation of Societies of Biological Psychiatry. Checked 2026-10-17.
- Portman Clinic — North London NHS Foundation Trust. Checked 2026-10-17.
- Medication to reduce male sex drive: guidance on referral, assessment and pharmacological treatment — Forensic Network and School of Forensic Mental Health. Checked 2026-10-17.
- Hypersexuality: fluoxetine — key points from the evidence — NICE. Checked 2026-10-17.
- Disruptive Mood Dysregulation Disorder: DSM-5 fact sheet — American Psychiatric Association. Checked 2026-10-17.
- DSM-5-TR September 2024 update: DMDD differential diagnosis — American Psychiatric Association. Checked 2026-10-17.
- Understanding the Brain Mechanisms of Irritability in Youth: archived 2018 research report — NIMH. Checked 2026-10-17.
- Behavioural problems for parents and carers — Royal College of Psychiatrists. Checked 2026-10-17.
- Helping your child with anger issues — NHS. Checked 2026-10-17.
- Comparing the DSM-5 construct of Disruptive Mood Dysregulation Disorder and ICD-10 Mixed Disorder of Emotion and Conduct in the UK Longitudinal Assessment of Manic Symptoms (UK-LAMS) Study — Sagar-Ouriaghli and colleagues; European Child & Adolescent Psychiatry / PubMed. Checked 2026-10-17.
- Separation anxiety in children — MedlinePlus Medical Encyclopedia. Checked 2026-10-17.
- Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety (2008) — Walkup and colleagues; New England Journal of Medicine. Checked 2026-10-17.
- The Matrix: Separation Anxiety — NHS Education for Scotland / Scottish Government. Checked 2026-10-17.
- Anxiety disorders — World Health Organization. Checked 2026-10-17.
- Adult separation anxiety in treatment nonresponders with anxiety disorders: delineation of the syndrome and exploration of attachment-based psychotherapy and biomarkers — Milrod and colleagues; Comprehensive Psychiatry / PubMed. Checked 2026-10-17.
- Buprenorphine 2 mg sublingual tablets: UK SmPC — G.L. Pharma UK Limited / emc. Checked 2026-10-17.
- Buprenorphine sublingual tablets: patient leaflet — G.L. Pharma UK Limited / emc. Checked 2026-10-17.
- Oral methadone and buprenorphine: recommendations — Department of Health and Social Care. Checked 2026-10-17.
- Treating opioid dependence during breastfeeding — NHS Specialist Pharmacy Service. Checked 2026-10-17.
- Buprenorphine Sublingual 2 mg Tablets: UK SmPC — Aurobindo Pharma – Milpharm Ltd / emc. Checked 2026-10-17.
- Espranor 2 mg oral lyophilisate: UK SmPC — Martindale Pharmaceuticals Ltd / emc. Checked 2026-10-17.
- Buvidal 8 mg prolonged-release injection: UK SmPC — Camurus AB / emc. Checked 2026-10-17.
- Buprenorphine/Naloxone G.L. Pharma 4 mg/1 mg sublingual tablets: UK SmPC — MHRA / G.L. Pharma GmbH. Checked 2026-10-17.
- BuTrans 15 microgram/hour patch: UK SmPC — Napp Pharmaceuticals Limited / emc. Checked 2026-10-17.
- Supplying take home naloxone without a prescription — Department of Health and Social Care. Checked 2026-10-17.
- Drug misuse and dependence: UK guidelines on clinical management (2017) — UK health departments. Checked 2026-10-17.
- Buprenorphine/naloxone (Suboxone) sublingual film: supply discontinued — Scottish Medicines Consortium. Checked 2026-10-17.
- Espranor: current emc product records — emc. Checked 2026-10-17.
- Buprenorphine-containing treatments: current prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Sublocade prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Initiating Buprenorphine Treatment in the Emergency Department — mechanism explanation — National Institute on Drug Abuse. Checked 2026-10-24.
- Sublocade updated FDA prescribing information — US Food and Drug Administration. Checked 2026-10-17.
- Brixadi updated FDA prescribing information — US Food and Drug Administration. Checked 2026-10-17.
- Buprenorphine-containing treatments: verified neutral parent, PubChem CID 644073 — NCBI PubChem. Checked 2026-10-17.
- Methadone 1 mg/mL oral solution sugar-free: UK SmPC — Martindale Pharma / emc. Checked 2026-10-17.
- Methadone 1 mg/mL oral solution sugar-free: patient leaflet — Martindale Pharma / emc. Checked 2026-10-17.
- About methadone — NHS. Checked 2026-10-17.
- Methadose 10 mg/1 mL oral concentrate: patient leaflet — Rosemont Pharmaceuticals Limited / emc. Checked 2026-10-17.
- Methadose 10 mg/1 mL oral concentrate: UK SmPC — Rosemont Pharmaceuticals Limited / emc. Checked 2026-10-17.
- How and when to take methadone — NHS. Checked 2026-10-17.
- Methadone: current prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Methadone: verified neutral parent, PubChem CID 4095 — NCBI PubChem. Checked 2026-10-17.
- Topiramate Milpharm 25 mg tablets: UK SmPC — Aurobindo Pharma – Milpharm Ltd / emc. Checked 2026-10-17.
- Topamax 25 mg tablets — UK SmPC — Marketing authorisation holder / eMC. Checked 2026-10-30.
- Topiramate — NHS. Checked 2026-10-17.
- Topiramate: Pregnancy Prevention Programme and new safety measures — MHRA. Checked 2026-10-17.
- Topamax 15 mg Sprinkle Hard Capsules: UK SmPC — Janssen-Cilag Ltd / emc. Checked 2026-10-17.
- Topiramate Rosemont 20 mg/mL oral suspension: UK SmPC — Rosemont Pharmaceuticals Ltd / emc. Checked 2026-10-17.
- Topamax tablets and sprinkle capsules: US prescribing information, March 2026 — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Topiramate: verified neutral parent, PubChem CID 5284627 — NCBI PubChem. Checked 2026-10-17.
- Metformin 500 mg film-coated tablets: UK SmPC — Brown & Burk UK Ltd / emc. Checked 2026-10-17.
- Metformin — NHS. Checked 2026-10-17.
- Metformin and reduced vitamin B12 levels: monitoring advice — MHRA. Checked 2026-10-17.
- South East London Joint Medicines Formulary: biguanides — South East London Integrated Medicines Optimisation Committee. Checked 2026-10-17.
- Metformin 500 mg and 850 mg film-coated tablets: patient leaflet — Brown & Burk UK Ltd / emc. Checked 2026-10-17.
- Antipsychotics prescribing guideline V2.3 — Nottinghamshire Area Prescribing Committee. Checked 2026-10-17.
- Metformin for the Prevention of Antipsychotic-Induced Weight Gain: Guideline Development and Consensus Validation — Schizophrenia Bulletin / guideline authors; PubMed Central. Checked 2026-10-17.
- Glucophage SR 500 mg prolonged-release tablets: UK SmPC — Merck Serono Ltd / emc. Checked 2026-10-17.
- Glucophage SR 500 mg, 750 mg and 1000 mg prolonged-release tablets: patient leaflet — Merck Serono Ltd / emc. Checked 2026-10-17.
- Antipsychotic weight-gain guideline CLG105 V1.1 — Gloucestershire Health and Care NHS Foundation Trust. Checked 2026-10-17.
- Metformin Colonis 500 mg/5 mL oral solution: UK SmPC — Colonis Pharma Ltd / emc. Checked 2026-10-17.
- Using antidiabetic medicines during breastfeeding — NHS Specialist Pharmacy Service. Checked 2026-10-17.
- Metformin hydrochloride tablets: prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Metformin: patient information — mechanism explanation — NIH / MedlinePlus. Checked 2026-10-24.
- Metformin: verified neutral parent, PubChem CID 4091 — NCBI PubChem. Checked 2026-10-17.
- Antidepressants: use and safety — MHRA. Checked 2026-10-17.
- Pristiq extended-release prescribing information — mechanism explanation — National Library of Medicine, DailyMed. Checked 2026-10-24.
- Desvenlafaxine: patient medicine information — American Society of Health-System Pharmacists / MedlinePlus. Checked 2026-10-17.
- Wyeth Europa withdraws its marketing-authorisation application for Pristiqs (desvenlafaxine) — European Medicines Agency. Checked 2026-10-17.
- Prescribing unlicensed medicines — General Medical Council. Checked 2026-11-04.
- Understanding unlicensed medicines — NHS Specialist Pharmacy Service. Checked 2026-10-17.
- Antipsychotic medicines: ziprasidone formulary entry — Nottinghamshire Area Prescribing Committee / NHS formulary. Checked 2026-10-17.
- Off-label and unlicensed prescribing — NHS Greater Glasgow and Clyde / Right Decisions. Checked 2026-10-17.
- Geodon (ziprasidone) capsules and injection: prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Ziprasidone: patient medicine information — American Society of Health-System Pharmacists / MedlinePlus. Checked 2026-10-17.
- Benzatropine injection for acute dystonic reactions — NHS Specialist Pharmacy Service. Checked 2026-10-17.
- Benzatropine injection: New Zealand data sheet — Phebra New Zealand / Medsafe. Checked 2026-10-17.
- Benztropine mesylate injection: US product label — Hikma / US National Library of Medicine DailyMed. Checked 2026-10-17.
- Benztropine: patient information — mechanism explanation — NIH / MedlinePlus. Checked 2026-10-24.
- Benztropine mesylate tablets: prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Bolden, Cusack and Richelson: Antagonism by antimuscarinic and neuroleptic compounds at the five cloned human muscarinic cholinergic receptors expressed in Chinese hamster ovary cells — mechanism explanation — Primary research, Journal of Pharmacology and Experimental Therapeutics / NLM PubMed. Checked 2026-10-24.
- What is Gender Dysphoria? — American Psychiatric Association. Checked 2026-10-17.
- Gender incongruence and transgender health in the ICD — World Health Organization. Checked 2026-10-17.
- Gender dysphoria and incongruence — NHS. Checked 2026-10-17.
- Patients and parents — National CYP Gender Referral Support Service — NHS National CYP Gender Referral Support Service. Checked 2026-10-17.
- Updated guidance to primary care about unregulated providers who supply hormone medications to children and young people for gender incongruence — NHS England. Checked 2026-10-17.
- NHSE policy on masculinising and feminising hormones — HCWS1391 — Department of Health and Social Care / UK Parliament. Checked 2026-10-17.
- Hormone treatments and age of consent: Government policy — House of Lords Library. Checked 2026-10-17.
- Puberty suppressing hormones for children and young people who have gender incongruence / gender dysphoria — NHS England. Checked 2026-10-17.
- The Medicines (Gonadotrophin-Releasing Hormone Analogues) (Restrictions on Private Sales and Supplies) Order 2024 — UK legislation / The National Archives. Checked 2026-10-17.
- Update on the PATHWAYS clinical trial — MHRA. Checked 2026-10-17.
- PATHWAYS trial — King's College London. Checked 2026-10-17.
- Welsh Gender Service — Your referral and appointment — Cardiff and Vale University Health Board. Checked 2026-10-17.
- Details of the independent clinical review of referrals for gender-affirming surgery — 6th October 2026 — NHS Wales Joint Commissioning Committee. Checked 2026-10-17.
- Accessing adult gender identity healthcare in Scotland — NHS inform. Checked 2026-10-17.
- Gender identity healthcare: evaluation of the impact of Scottish Government funding — young people's service — Scottish Government. Checked 2026-10-17.
- Cass review: implications for Scotland — letter from Chief Medical Officer Professor Sir Gregor Smith — Scottish Government / Chief Medical Officer. Checked 2026-10-17.
- Knowing Our Identity — Belfast Health and Social Care Trust. Checked 2026-10-17.
- Brackenburn Clinic — Belfast Health and Social Care Trust. Checked 2026-10-17.
- AQW 40761/22-27 — Gender Identity Service and PATHWAYS trial — Northern Ireland Assembly / Minister of Health. Checked 2026-10-17.
- Amfexa 10 mg tablets: UK SmPC — Medice UK Ltd / emc. Checked 2026-10-17.
- Amfexa 5 mg tablets: UK SmPC — Medice UK Ltd / emc. Checked 2026-10-17.
- Amfexa: patient leaflet — Medice UK Ltd / emc. Checked 2026-10-17.
- Amfexa 20 mg tablets: UK SmPC — Medice UK Ltd / emc. Checked 2026-10-17.
- Dexamfetamine sulfate 1 mg/mL oral solution: UK SmPC — Rosemont Pharmaceuticals Ltd / emc. Checked 2026-10-17.
- Dexamfetamine sulfate 1 mg/mL oral solution: patient leaflet — Rosemont Pharmaceuticals Ltd / emc. Checked 2026-10-17.
- Dexamfetamine sulfate 5 mg tablets: UK SmPC — Brown & Burk UK Ltd / emc. Checked 2026-10-17.
- Dexamfetamine and lisdexamfetamine for narcolepsy: local information sheet v3.0 — Nottinghamshire Area Prescribing Committee. Checked 2026-10-17.
- Zenzedi (dextroamphetamine) tablets: prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Adderall (mixed amphetamine salts) tablets: prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Dexedrine Spansule (dextroamphetamine sulfate) sustained-release capsules: prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Adderall XR (mixed amphetamine salts): prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Dextroamphetamine: verified neutral parent, PubChem CID 5826 — NCBI PubChem. Checked 2026-10-17.
- Cardura 1 mg tablets: UK SmPC — Viatris Products Limited / emc. Checked 2026-10-17.
- Cardura 1 mg and 2 mg tablets: patient leaflet — Viatris Products Limited / emc. Checked 2026-10-17.
- Doxazosin — NHS. Checked 2026-10-17.
- Cardura XL 4 mg prolonged-release tablets: UK SmPC — Viatris Products Limited / emc. Checked 2026-10-17.
- Cardura XL 8 mg prolonged-release tablets: UK SmPC — Viatris Products Limited / emc. Checked 2026-10-17.
- Doxazosin 0.4 mg/mL oral suspension: UK SmPC — Syri Limited trading as SyriMed / emc. Checked 2026-10-17.
- Switching doxazosin XL tablets to doxazosin standard tablets — NHS Specialist Pharmacy Service. Checked 2026-10-17.
- Doxazosin tablets: prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Doxazosin: patient information — mechanism explanation — NIH / MedlinePlus. Checked 2026-10-24.
- Cardura immediate-release: current US prescribing information — US National Library of Medicine / DailyMed. Checked 2026-10-17.
- Cardura XL: current US prescribing information — US National Library of Medicine / DailyMed. Checked 2026-10-17.
- Richards and colleagues: randomized doxazosin trial for posttraumatic dreams and sleep, 2025 — Journal of Clinical Sleep Medicine / PubMed. Checked 2026-10-17.
- Doxazosin: verified neutral parent, PubChem CID 3157 — NCBI PubChem. Checked 2026-10-17.
- Atenolol 25 mg tablets: UK SmPC — Ipca Laboratories UK Ltd / emc. Checked 2026-10-17.
- Atenolol 25, 50 and 100 mg tablets: patient leaflet — Ipca Laboratories UK Ltd / emc. Checked 2026-10-17.
- Atenolol — NHS. Checked 2026-10-17.
- Atenolol oral solution 25 mg/5 mL: UK SmPC — Rosemont Pharmaceuticals Ltd / emc. Checked 2026-10-17.
- Atenolol 25 mg/5 mL sugar-free oral solution: patient leaflet — Rosemont Pharmaceuticals Ltd / emc. Checked 2026-10-17.
- Tenormin (atenolol): prescribing information — mechanism explanation — US Food and Drug Administration. Checked 2026-10-24.
- Atenolol: patient information — mechanism explanation — NIH / MedlinePlus. Checked 2026-10-24.
- Atenolol: current selected US product prescribing information — US National Library of Medicine / DailyMed. Checked 2026-10-17.
- Atenolol: PubChem CID 2249 — NCBI PubChem. Checked 2026-10-17.
- Trihexyphenidyl hydrochloride 5 mg/5 mL syrup: UK SmPC — Rosemont Pharmaceuticals Ltd / emc. Checked 2026-10-17.
- Trihexyphenidyl syrup: patient leaflet — Rosemont Pharmaceuticals Ltd / emc. Checked 2026-10-17.
- Trihexyphenidyl titration: patient information — King's College Hospital NHS Foundation Trust. Checked 2026-10-17.
- Trihexyphenidyl hydrochloride: abbreviated prescribing information — Rosemont Pharmaceuticals Ltd. Checked 2026-10-17.
- Crescent Pharma product portfolio: trihexyphenidyl 2 mg and 5 mg tablets — Crescent Pharma. Checked 2026-10-17.
- Trihexyphenidyl 2 mg Tablets: UK Summary of Product Characteristics — Ennogen IP Ltd / MHRA. Checked 2026-10-18.
- Trihexyphenidyl 5 mg Tablets: UK Summary of Product Characteristics — Ennogen IP Ltd / MHRA. Checked 2026-10-18.
- Trihexyphenidyl 2 mg and 5 mg Tablets: patient information leaflet — Ennogen IP Ltd / MHRA. Checked 2026-10-18.
- Trihexyphenidyl hydrochloride tablets: prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Trihexyphenidyl: patient information — mechanism explanation — NIH / MedlinePlus. Checked 2026-10-24.
- An evidence-based update on anticholinergic use for drug-induced movement disorders — Vanegas-Arroyave and colleagues, CNS Drugs (2024). Checked 2026-10-17.
- Trihexyphenidyl: supplementary ingredient safety labeling (Bionpharma products have ended marketing) — US National Library of Medicine / DailyMed. Checked 2026-10-17.
- Trihexyphenidyl: PubChem CID 5572 — NCBI PubChem. Checked 2026-10-17.
- Lunivia 1 mg film-coated tablets: UK SmPC — axunio Pharma GmbH / emc. Checked 2026-10-17.
- Lunivia 3 mg film-coated tablets: UK SmPC — axunio Pharma GmbH / emc. Checked 2026-10-17.
- Lunivia: patient leaflet — axunio Pharma GmbH / emc. Checked 2026-10-17.
- Lunivia: withdrawn application — European Medicines Agency. Checked 2026-10-17.
- Lunivia 2 mg film-coated tablets: UK SmPC — axunio Pharma GmbH / emc. Checked 2026-10-17.
- Eszopiclone — UK product-information inventory — emc. Checked 2026-10-17.
- Lunesta: current prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Eszopiclone: MedlinePlus Drug Information — mechanism explanation — US National Library of Medicine / MedlinePlus. Checked 2026-10-24.
- Lunesta: FDA prescribing information — US Food and Drug Administration. Checked 2026-10-17.
- Eszopiclone: verified neutral parent, PubChem CID 969472 — NCBI PubChem. Checked 2026-10-17.
- Hydroxyzine hydrochloride 25 mg film-coated tablets: UK SmPC — mechanism explanation — Morningside Healthcare Ltd / electronic medicines compendium. Checked 2026-10-24.
- Hydroxyzine 10 mg and 25 mg tablets: patient leaflet — Morningside Healthcare Ltd / emc. Checked 2026-10-17.
- Hydroxyzine: QT prolongation and torsade de pointes — MHRA. Checked 2026-10-17.
- Hydroxyzine 10 mg film-coated tablets: UK SmPC — Morningside Healthcare Ltd / emc. Checked 2026-10-17.
- Hydroxyzine hydrochloride — UK product-information inventory — emc. Checked 2026-10-17.
- Hydroxyzine pamoate capsules prescribing information — mechanism explanation — National Library of Medicine, DailyMed. Checked 2026-10-24.
- Hydroxyzine hydrochloride tablets prescribing information — mechanism explanation — National Library of Medicine, DailyMed. Checked 2026-10-24.
- Hydroxyzine drug information — mechanism explanation — National Library of Medicine, MedlinePlus. Checked 2026-10-24.
- The relative antihistaminic and psychomotor effects of hydroxyzine and cetirizine — mechanism explanation — Gengo and colleagues, Clinical Pharmacology & Therapeutics; indexed by National Library of Medicine. Checked 2026-10-24.
- Cetirizine: actions on neurotransmitter receptors — mechanism explanation — Snowman and Snyder, Journal of Allergy and Clinical Immunology; indexed by National Library of Medicine. Checked 2026-10-24.
- Hydroxyzine: verified neutral parent, PubChem CID 3658 — NCBI PubChem. Checked 2026-10-17.
- Doxepin 25 mg Capsules: UK SmPC — mechanism explanation — Zentiva Pharma UK Limited / electronic medicines compendium. Checked 2026-10-24.
- Doxepin 25 mg hard capsules: UK SmPC — Aurobindo Pharma – Milpharm Ltd / emc. Checked 2026-10-17.
- Doxepin 25 mg and 50 mg capsules: patient leaflet — Zentiva / emc. Checked 2026-10-17.
- Doxepin 10 mg capsules: UK SmPC — Morningside Healthcare Ltd / emc. Checked 2026-10-17.
- Doxepin 50 mg capsules: UK SmPC — Zentiva Pharma UK Limited / emc. Checked 2026-10-17.
- Sinepin 25 mg capsules: UK SmPC — Marlborough Pharmaceuticals Ltd / emc. Checked 2026-10-17.
- Doxepin — UK product-information inventory — emc. Checked 2026-10-17.
- Doxepin hydrochloride capsules prescribing information — mechanism explanation — National Library of Medicine, DailyMed. Checked 2026-10-24.
- Silenor prescribing information — mechanism explanation — National Library of Medicine, DailyMed. Checked 2026-10-24.
- Doxepin: verified neutral parent, PubChem CID 3158 — NCBI PubChem. Checked 2026-10-17.
- Campral EC 333 mg gastro-resistant tablets — patient leaflet, sections 1–4 and 6 — Merck Serono Limited. Checked 2026-10-17.
- Campral EC — SmPC, sections 4.1–4.9, 5.1–5.2 and 7–10 — Merck Serono Limited. Checked 2026-10-17.
- Acamprosate 333 mg gastro-resistant tablets — SmPC, sections 4–5 — Generics [UK] Limited t/a Mylan (Viatris). Checked 2026-10-17.
- Acamprosate calcium delayed-release tablets: current generic prescribing information — mechanism explanation — DailyMed / Zydus. Checked 2026-10-24.
- Amitriptyline 10 mg Film-Coated Tablets: UK SmPC — mechanism explanation — Brown & Burk UK Ltd / electronic medicines compendium. Checked 2026-10-24.
- Amitriptyline 25 mg — UK SmPC — Brown & Burk UK Ltd / emc. Checked 2026-10-17.
- Amitriptyline 50 mg — UK SmPC — Brown & Burk UK Ltd / emc. Checked 2026-10-17.
- Amitriptyline — patient leaflet — Brown & Burk UK Ltd / emc. Checked 2026-10-17.
- NHS: Amitriptyline side effects — NHS. Checked 2026-10-17.
- NHS: About amitriptyline for depression — NHS. Checked 2026-10-17.
- Amitriptyline hydrochloride 10 mg/5 mL oral solution — SmPC — SyriMed. Checked 2026-10-17.
- Amitriptyline hydrochloride tablets prescribing information — mechanism explanation — National Library of Medicine, DailyMed. Checked 2026-10-24.
- Abilify 5 mg tablets — UK SmPC — Otsuka Pharmaceutical Netherlands B.V.. Checked 2026-10-17.
- Abilify 1 mg/mL oral solution — UK SmPC — Otsuka Pharmaceutical Netherlands B.V.. Checked 2026-10-17.
- About aripiprazole — NHS. Checked 2026-10-17.
- Taking aripiprazole — NHS. Checked 2026-10-17.
- Aripiprazole side effects — NHS. Checked 2026-10-17.
- Aripiprazole in pregnancy and breastfeeding — NHS. Checked 2026-10-17.
- Aripiprazole interactions — NHS. Checked 2026-10-17.
- Aripiprazole: risk of pathological gambling — MHRA. Checked 2026-10-17.
- Aripiprazole: reminder on known risk of gambling disorder — MHRA. Checked 2026-10-17.
- Aripiprazole Otsuka 400 mg pre-filled syringe — SmPC — Otsuka Pharmaceuticals (UK) Ltd. Checked 2026-10-17.
- Aripiprazole Otsuka 960 mg pre-filled syringe — SmPC — Otsuka Pharmaceuticals (UK) Ltd. Checked 2026-10-17.
- Abilify 7.5 mg/mL solution for injection — SmPC — Otsuka Pharmaceuticals (UK) Ltd. Checked 2026-10-17.
- Abilify 10 mg orodispersible tablet — SmPC — Otsuka Pharmaceuticals (UK) Ltd. Checked 2026-10-17.
- Abilify (aripiprazole): prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- PubChem: aripiprazole, CID 60795 — NCBI PubChem. Checked 2026-10-16.
- Atomoxetine capsules: SmPC, sections 1–5 — Aspire Pharma Ltd / electronic medicines compendium. Checked 2026-10-17.
- Atomoxetine 10–100 mg capsules: patient leaflet, sections 1–4 — Aspire Pharma Ltd / electronic medicines compendium. Checked 2026-10-17.
- Atomoxetine: increases in blood pressure and heart rate (article dated January 2012) — MHRA. Checked 2026-10-17.
- Atomoxetine 4 mg/mL oral solution: UK SmPC — Consilient Health Limited. Checked 2026-10-17.
- Consilient Health UK product catalogue: Atomoxetine oral solution — Consilient Health. Checked 2026-10-17.
- Lincolnshire Joint Formulary: CNS stimulants and ADHD medicines — Lincolnshire Joint Formulary / NHS. Checked 2026-10-17.
- Strattera (atomoxetine): prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Atomoxetine / Strattera: FDA prescribing information, June 2026 — US Food and Drug Administration. Checked 2026-10-16.
- Zyban: patient leaflet — GlaxoSmithKline / emc. Checked 2026-10-17.
- Quit smoking with nicotine-free medicines — mechanism explanation — NHS. Checked 2026-10-24.
- MHRA: Bupropion and serotonin syndrome with other serotonergic medicines — MHRA. Checked 2026-10-17.
- Yorkshire Smokefree: Bupropion overview and administration — South West Yorkshire Partnership NHS Foundation Trust. Checked 2026-10-17.
- NENC: Bupropion for resistant depression—local primary-care information, February 2025 — NHS North East and North Cumbria / NTAG. Checked 2026-10-17.
- Wellbutrin XL prescribing information — mechanism explanation — U.S. Food and Drug Administration. Checked 2026-10-24.
- DailyMed: Wellbutrin XL, updated February2026 — Official labeling / National Library of Medicine. Checked 2026-10-16.
- PubChem: Bupropion parent compound and 2D record — NCBI PubChem. Checked 2026-10-16.
- Tegretol 100 mg, 200 mg and 400 mg tablets — UK SmPC — Novartis Pharmaceuticals UK Limited. Checked 2026-10-17.
- Tegretol tablets — UK patient leaflet — Novartis Pharmaceuticals UK Limited. Checked 2026-10-17.
- Carbamazepine — NHS. Checked 2026-10-17.
- Carbamazepine monitoring — NHS Specialist Pharmacy Service. Checked 2026-10-17.
- Trileptal 150 mg, 300 mg and 600 mg tablets — UK SmPC — Novartis Ireland Limited. Checked 2026-10-17.
- Tegretol 100 mg/5 mL liquid — UK SmPC — Novartis Pharmaceuticals UK Ltd. Checked 2026-10-17.
- Tegretol 200 mg and 400 mg prolonged-release tablets — UK SmPC — Novartis Pharmaceuticals UK Ltd. Checked 2026-10-17.
- Carbamazepine: current prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- McLean and Macdonald: Carbamazepine and its epoxide limit rapidly firing action potentials — mechanism explanation — National Library of Medicine / PubMed. Checked 2026-10-24.
- Reagila hard capsules — UK SmPC — Gedeon Richter Plc.. Checked 2026-10-17.
- Reagila 1.5 mg, 3 mg, 4.5 mg and 6 mg capsules — UK patient leaflet — Gedeon Richter Plc.. Checked 2026-10-17.
- Vraylar (cariprazine): prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Cipramil 20 mg: UK SmPC — Lundbeck / emc. Checked 2026-10-17.
- Cipramil Drops: UK SmPC — Lundbeck / emc. Checked 2026-10-17.
- Citalopram — mechanism explanation — NHS. Checked 2026-10-24.
- MHRA: Citalopram and escitalopram—QT interval prolongation — MHRA. Checked 2026-10-17.
- Citalopram 10 mg tablets (Milpharm): UK SmPC — Milpharm Limited / electronic medicines compendium. Checked 2026-10-17.
- Citalopram 40 mg tablets (Milpharm): UK SmPC — Milpharm Limited / electronic medicines compendium. Checked 2026-10-17.
- Celexa prescribing information — mechanism explanation — U.S. Food and Drug Administration. Checked 2026-10-24.
- Lexapro prescribing information — mechanism explanation — U.S. Food and Drug Administration. Checked 2026-10-24.
- DailyMed: Celexa tablets — NLM DailyMed. Checked 2026-10-16.
- PubChem: Citalopram parent compound and verified 2D record — NCBI PubChem. Checked 2026-10-16.
- Clomipramine 10 mg Capsules, Hard: UK SmPC — mechanism explanation — Generics (U.K.) Limited T/A Viatris / electronic medicines compendium. Checked 2026-10-24.
- Clomipramine 25 mg — UK SmPC — Generics (U.K.) Limited T/A Viatris / emc. Checked 2026-10-17.
- Clomipramine 50 mg — UK SmPC — Generics (U.K.) Limited T/A Viatris / emc. Checked 2026-10-17.
- Clomipramine 10, 25 and 50 mg — patient leaflet — Generics (U.K.) Limited T/A Viatris / emc. Checked 2026-10-17.
- Oxford Health NHS Foundation Trust formulary: clomipramine/Anafranil SR status — Oxford Health NHS Foundation Trust. Checked 2026-10-17.
- Anafranil prescribing information — mechanism explanation — National Library of Medicine, DailyMed. Checked 2026-10-24.
- NHS: common questions about clonazepam — NHS. Checked 2026-10-17.
- Clonazepam Aristo 0.5 mg tablets — SmPC, sections 4.1–4.9, 5.1–5.2 and 7–10 — Aristo Pharma GmbH. Checked 2026-10-17.
- Clonazepam Thame 0.5 mg/5 ml oral solution — SmPC, sections 4.1–4.9, 5.1–5.2 and 7–10 — Syri Limited t/a Thame Laboratories. Checked 2026-10-17.
- Clonazepam Aristo 0.5 mg and 2 mg tablets — patient leaflet, sections 1–4 and 6 — Aristo Pharma GmbH. Checked 2026-10-17.
- Oral benzodiazepines and choosing equivalent doses — differences and licensed indications — NHS Specialist Pharmacy Service. Checked 2026-10-17.
- Klonopin tablets: current prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Clonazepam: MedlinePlus Drug Information — mechanism explanation — US National Library of Medicine / MedlinePlus. Checked 2026-10-24.
- Clonidine 25 microgram Tablets BP: SmPC, sections 1–5 and 9 — Sandoz Limited / electronic medicines compendium. Checked 2026-10-17.
- Clonidine hydrochloride 100 microgram tablets: SmPC, sections 1–4 — Flamingo Pharma (UK) Ltd / electronic medicines compendium. Checked 2026-10-17.
- Common questions about clonidine: mechanism, withdrawal and specialist uses — NHS. Checked 2026-10-17.
- Side effects of clonidine — NHS. Checked 2026-10-17.
- Clonidine hydrochloride extended-release tablets: prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Kapvay: FDA reference-product label — US Food and Drug Administration. Checked 2026-10-16.
- Clonidine: verified parent compound, PubChem CID 2803 — NCBI PubChem. Checked 2026-10-16.
- Clozaril 100 mg tablets — UK SmPC — Viatris Products Limited. Checked 2026-10-17.
- Clozaril 25 mg and 100 mg tablets — UK patient leaflet — Viatris Products Limited. Checked 2026-10-17.
- Clinical considerations for patients prescribed clozapine — NHS Specialist Pharmacy Service. Checked 2026-10-17.
- Clozapine: potentially fatal bowel obstruction risk — MHRA. Checked 2026-10-17.
- Denzapine 50 mg/mL oral suspension — UK SmPC — Britannia Pharmaceuticals Limited. Checked 2026-10-17.
- Zaponex 12.5, 25, 50, 100 and 200 mg orodispersible tablets — UK SmPC — Leyden Delta BV. Checked 2026-10-17.
- Clozaril (clozapine): prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Quviviq 25 mg and 50 mg film-coated tablets — patient leaflet, sections 1–4 and 6 — Idorsia Pharmaceuticals Deutschland GmbH. Checked 2026-10-17.
- SMC2611: daridorexant — public summary of restricted acceptance in NHS Scotland — Scottish Medicines Consortium. Checked 2026-10-17.
- Quviviq 50 mg film-coated tablets — SmPC, sections 4.1–4.9, 5.1–5.2 and 7–10 — Idorsia Pharmaceuticals Deutschland GmbH. Checked 2026-10-17.
- Zalzo 5 mg orodispersible tablets — SmPC, sections 4.1–4.9, 5.1–5.2 and 7–10 — Novumgen Limited. Checked 2026-10-17.
- Quviviq 25 mg film-coated tablets — SmPC, sections 4.1–4.5 — Idorsia Pharmaceuticals Deutschland GmbH. Checked 2026-10-17.
- Quviviq 25 mg and 50 mg — current patient leaflet, sections 1–4 — Idorsia Pharmaceuticals UK Ltd. Checked 2026-10-17.
- daridorexant: current US prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- NHS: diazepam — NHS. Checked 2026-10-17.
- Diazepam 2 mg tablets — SmPC, sections 4.1–4.9, 5.1–5.2 and 7–10 — Waymade plc trading as Sovereign Medical. Checked 2026-10-17.
- Diazepam 2 mg, 5 mg and 10 mg tablets — patient leaflet, sections 1–4 and 6 — Waymade plc trading as Sovereign Medical. Checked 2026-10-17.
- Diazepam 2 mg/5 mL oral suspension — SmPC — Sandoz Limited. Checked 2026-10-17.
- Diazepam Desitin 10 mg rectal solution — SmPC, including 5 mg presentation — Desitin Pharma Ltd. Checked 2026-10-17.
- Diazepam Injection BP — SmPC — hameln pharma ltd. Checked 2026-10-17.
- Valium oral tablets: current October 2026 prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Diazepam: MedlinePlus Drug Information — mechanism explanation — US National Library of Medicine / MedlinePlus. Checked 2026-10-24.
- Disulfiram 200 mg tablets — SmPC, sections 4.1–4.9, 5.1–5.2 and 7–10 — Brown & Burk UK Ltd. Checked 2026-10-17.
- Disulfiram 200 mg tablets — patient leaflet, sections 1–4 and 6 — Brown & Burk UK Ltd. Checked 2026-10-17.
- Disulfiram: current prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Incorporating Alcohol Pharmacotherapies Into Medical Practice: Chapter 3—Disulfiram — mechanism explanation — Substance Abuse and Mental Health Services Administration / NCBI Bookshelf. Checked 2026-10-24.
- Duloxetine Zentiva 30 mg: UK SmPC — Zentiva / emc. Checked 2026-10-17.
- Duloxetine Zentiva 30/60 mg: patient leaflet — Zentiva / emc. Checked 2026-10-17.
- NHS: Duloxetine — NHS. Checked 2026-10-17.
- MHRA: Duloxetine products for different disorders (historical safety article) — MHRA. Checked 2026-10-17.
- Duloxetine 20 mg gastro-resistant capsules — Amarox SmPC — Amarox Limited. Checked 2026-10-17.
- Duloxetine 40 mg gastro-resistant capsules — Amarox SmPC — Amarox Limited. Checked 2026-10-17.
- Yentreve 20/40 mg — discontinued emc product record and historical SmPC — Eli Lilly and Company Limited. Checked 2026-10-17.
- Cymbalta prescribing information — mechanism explanation — U.S. Food and Drug Administration. Checked 2026-10-24.
- DailyMed: duloxetine delayed-release capsules, current generic labeling — NLM DailyMed. Checked 2026-10-16.
- PubChem: Duloxetine parent compound and verified 2D record — NCBI PubChem. Checked 2026-10-16.
- Cipralex oral drops: UK SmPC — Lundbeck / emc. Checked 2026-10-17.
- Cipralex tablets: patient leaflet — Lundbeck / emc. Checked 2026-10-17.
- NHS: Escitalopram — NHS. Checked 2026-10-17.
- Enalto 10 mg orodispersible tablets — SmPC — Novumgen Limited (emc). Checked 2026-10-17.
- PubChem: Escitalopram parent compound and 2D record — NCBI PubChem. Checked 2026-10-16.
- Fluoxetine capsules: patient leaflet — Flamingo Pharma / emc. Checked 2026-10-17.
- NHS: Fluoxetine — NHS. Checked 2026-10-17.
- Drugs@FDA: Prozac original approval history (US history only) — FDA. Checked 2026-10-17.
- Olena 20 mg dispersible tablets — SmPC — Mercury Pharmaceuticals Ltd / ADVANZ Pharma (emc). Checked 2026-10-17.
- Fluoxetine 20 mg/5 ml oral solution — SmPC — Morningside Healthcare Limited (emc). Checked 2026-10-17.
- Prozac prescribing information — mechanism explanation — U.S. Food and Drug Administration. Checked 2026-10-24.
- DailyMed: fluoxetine immediate-release capsules — NLM DailyMed. Checked 2026-10-16.
- PubChem: Fluoxetine parent compound and verified 2D record — NCBI PubChem. Checked 2026-10-16.
- Faverin 50 mg Film-coated Tablets: UK SmPC — mechanism explanation — Viatris Products Limited / electronic medicines compendium. Checked 2026-10-24.
- Faverin 100 mg — UK SmPC — Viatris Products Limited / emc. Checked 2026-10-17.
- Faverin 50 and 100 mg — patient leaflet — Viatris Products Limited / emc. Checked 2026-10-17.
- Fluvoxamine maleate tablets prescribing information — mechanism explanation — National Library of Medicine, DailyMed. Checked 2026-10-24.
- Fluvoxamine maleate extended-release capsules prescribing information — mechanism explanation — National Library of Medicine, DailyMed. Checked 2026-10-24.
- Fluvoxamine: verified neutral parent, PubChem CID 5324346 — NCBI PubChem. Checked 2026-10-17.
- Neurontin 100 mg capsules: SmPC, section 4.1 — Viatris Products Limited / electronic medicines compendium. Checked 2026-10-17.
- Neurontin capsules and tablets: patient leaflet, sections 1–4 — Viatris Products Limited / electronic medicines compendium. Checked 2026-10-17.
- Neurontin 600 mg tablets: SmPC, sections 2–4.2 — Viatris Products Limited / electronic medicines compendium. Checked 2026-10-17.
- Side effects of gabapentin — NHS. Checked 2026-10-17.
- Gabapentin: pregnancy, breastfeeding and fertility — NHS. Checked 2026-10-17.
- Gabapentin: risk of severe respiratory depression — MHRA. Checked 2026-10-17.
- Lyrica 75 mg hard capsules: SmPC, sections 4–5 — Viatris Products Limited / electronic medicines compendium. Checked 2026-10-17.
- Gabapentin Thame 50 mg/ml oral solution — SmPC — SyriMed (emc). Checked 2026-10-17.
- Neurontin capsules, tablets and oral solution: current prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Neurontin: FDA prescribing information, April 2025 — US Food and Drug Administration. Checked 2026-10-17.
- Gabapentin: verified neutral parent, PubChem CID 3446 — NCBI PubChem. Checked 2026-10-17.
- Intuniv 1, 2, 3 and 4 mg prolonged-release tablets: patient leaflet, sections 1–4 — Takeda / electronic medicines compendium. Checked 2026-10-17.
- Guanfacine (Intuniv), SMC 1123/16: advice and evidence, pages 1–7 — Scottish Medicines Consortium. Checked 2026-10-17.
- Intuniv (guanfacine) extended-release tablets: prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Intuniv: FDA label linked by Drugs@FDA — US Food and Drug Administration. Checked 2026-10-16.
- Guanfacine: verified parent compound, PubChem CID 3519 — NCBI PubChem. Checked 2026-10-16.
- Haldol 2 mg/ml oral solution — UK SmPC — Essential Pharma Limited. Checked 2026-10-17.
- Haldol 2 mg/ml oral solution — UK patient leaflet — Essential Pharma Limited. Checked 2026-10-17.
- Haloperidol: risks in elderly patients treated for acute delirium — MHRA. Checked 2026-10-17.
- Haldol Decanoate 50 mg/ml and 100 mg/ml solution for injection — UK SmPC — Essential Pharma Limited. Checked 2026-10-17.
- Haloperidol 5 mg/ml solution for injection — UK SmPC — Wockhardt UK Ltd. Checked 2026-10-17.
- Haloperidol 5 mg tablets — Teva UK SmPC — Teva UK Limited. Checked 2026-10-17.
- Haloperidol tablets: prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Haldol Decanoate (haloperidol decanoate): prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Haloperidol: verified neutral parent, PubChem CID 3559 — NCBI PubChem. Checked 2026-10-17.
- Lamotrigine — NHS. Checked 2026-10-17.
- Lamictal tablets — patient leaflet — The Wellcome Foundation Ltd. Checked 2026-10-17.
- Antiepileptic drugs in pregnancy: updated advice following comprehensive safety review — MHRA. Checked 2026-10-17.
- Lamictal in-use labeling and patient guide — mechanism explanation — National Library of Medicine. Checked 2026-10-24.
- Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na+ channels and with native Na+ channels in rat hippocampal neurones — mechanism explanation — Original research indexed by the National Library of Medicine / PubMed. Checked 2026-10-24.
- Lamictal prescribing information and Medication Guide (revised October 2025) — U.S. Food and Drug Administration. Checked 2026-10-16.
- Lamotrigine chemical record: PubChem CID 3878 — National Center for Biotechnology Information. Checked 2026-10-16.
- Verified two-dimensional atoms and bonds for lamotrigine — National Center for Biotechnology Information. Checked 2026-10-16.
- Elvanse 20–70 mg capsules — patient leaflet — Takeda UK Limited. Checked 2026-10-17.
- Lisdexamfetamine for adult services — local shared-care protocol — Nottinghamshire Area Prescribing Committee. Checked 2026-10-17.
- Elvanse: one dose range for children, adolescents and adults — Takeda UK, hosted by Nottinghamshire Area Prescribing Committee. Checked 2026-10-17.
- Vyvanse (lisdexamfetamine): prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Vyvanse: FDA prescribing information, April 2026 — US Food and Drug Administration. Checked 2026-10-16.
- How and when to take lithium — NHS. Checked 2026-10-17.
- Side effects of lithium — NHS. Checked 2026-10-17.
- Lithium in pregnancy and breastfeeding — NHS. Checked 2026-10-17.
- Lithium interactions — NHS. Checked 2026-10-17.
- Lithium monitoring — NHS Specialist Pharmacy Service. Checked 2026-10-17.
- Priadel 520 mg/5 ml liquid — SmPC — Essential Pharma Ltd (emc). Checked 2026-10-17.
- DailyMed: Hikma lithium carbonate current label and Medication Guide — mechanism explanation — NLM DailyMed. Checked 2026-10-24.
- FDA: lithium carbonate prescribing information and Medication Guide — FDA. Checked 2026-10-16.
- DailyMed: lithium carbonate tablets — Official labeling / National Library of Medicine. Checked 2026-10-16.
- NHS: common questions about lorazepam — NHS. Checked 2026-10-17.
- Lorazepam 1 mg tablets — SmPC, sections 4.1–4.9, 5.1–5.2 and 7–10 — Genus Pharmaceuticals Holdings Limited. Checked 2026-10-17.
- Lorazepam Aristo 1 mg orodispersible tablets — SmPC, sections 4.1–4.9, 5.1–5.2 and 7–10 — Aristo Pharma GmbH. Checked 2026-10-17.
- Lorazepam 1 mg and 2.5 mg tablets — patient leaflet, sections 1–4 and 6 — Genus Pharmaceuticals. Checked 2026-10-17.
- Lorazepam: original product approval and regulatory history — U.S. Food and Drug Administration. Checked 2026-10-16.
- Lorazepam Macure 4 mg/ml solution for injection — SmPC — Macure Pharma UK Ltd (emc). Checked 2026-10-17.
- Lorazepam 1 mg/ml oral solution — SmPC — SyriMed (emc). Checked 2026-10-17.
- Loreev XR prescribing information — receptor mechanism and formulation distinction — mechanism explanation — DailyMed / NLM. Checked 2026-10-24.
- Lorazepam: current product prescribing information — mechanism explanation — DailyMed / U.S. National Library of Medicine. Checked 2026-10-24.
- Lorazepam: verified parent compound, PubChem CID 3958 — NCBI PubChem. Checked 2026-10-16.
- Latuda 37 mg tablets — UK SmPC — CNX Therapeutics Ltd. Checked 2026-10-17.
- Latuda 18.5 mg, 37 mg and 74 mg tablets — UK patient leaflet — CNX Therapeutics Ltd. Checked 2026-10-17.
- Drugs@FDA: Latuda approval and regulatory history — US Food and Drug Administration. Checked 2026-10-16.
- Latuda (lurasidone): prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Medikinet XL 60 mg modified-release capsules — UK SmPC — Medice Arzneimittel Pütter GmbH & Co. KG. Checked 2026-10-17.
- Modified-release methylphenidate: caution when switching products — MHRA. Checked 2026-10-30.
- About methylphenidate for adults — NHS. Checked 2026-10-17.
- Taking methylphenidate for adults — NHS. Checked 2026-10-17.
- Methylphenidate side effects — NHS. Checked 2026-10-17.
- Methylphenidate in pregnancy and breastfeeding — NHS. Checked 2026-10-17.
- Ritalin 10 mg tablets — UK SmPC — INFECTOPHARM Arzneimittel und Consilium GmbH. Checked 2026-10-17.
- Ritalin (methylphenidate): prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Concerta (methylphenidate) extended-release tablets: prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Prescribing and switching between modified-release methylphenidate — NHS Specialist Pharmacy Service. Checked 2026-10-30.
- Ritalin: FDA prescribing information, February 2025 — US Food and Drug Administration. Checked 2026-10-16.
- Concerta: FDA prescribing information, April 2026 — US Food and Drug Administration. Checked 2026-10-16.
- Mirtazapine 15 mg tablets: SmPC, sections 1–5 and 7–10 — Milpharm Limited / electronic medicines compendium. Checked 2026-10-17.
- Mirtazapine: uses, safety and practical information — NHS. Checked 2026-10-17.
- Mirtazapine 15 mg/ml oral solution: SmPC, sections 2, 4.2–4.6 — Rosemont Pharmaceuticals Ltd / electronic medicines compendium. Checked 2026-10-17.
- Mirtazapine 15 mg orodispersible tablets: SmPC, sections 2–4.2 — Krka / electronic medicines compendium. Checked 2026-10-17.
- Remeron and RemeronSolTab prescribing information — mechanism explanation — U.S. Food and Drug Administration. Checked 2026-10-24.
- DailyMed: Remeron tablets and Remeron SolTab — NLM DailyMed. Checked 2026-10-16.
- PubChem: Mirtazapine parent compound and verified 2D record — NCBI PubChem. Checked 2026-10-16.
- Adepend 50 mg filmcoated tablets — SmPC, sections 4.1–4.9, 5.1–5.2 and 7–10 — Orpha-Devel Handels und Vertriebs GmbH. Checked 2026-10-17.
- Naltrexone hydrochloride 50 mg film-coated tablets — SmPC, sections 4.1–4.9, 5.1–5.2 and 7–10 — AOP Orphan Pharmaceuticals GmbH. Checked 2026-10-17.
- Naltrexone hydrochloride 50 mg tablets — patient leaflet, sections 1–4 and 6 — AOP Orphan Pharmaceuticals GmbH. Checked 2026-10-17.
- Adepend 50 mg film-coated tablets — patient leaflet, sections 1–4 and 6 — Orpha-Devel Handels und Vertriebs GmbH. Checked 2026-10-17.
- Oral naltrexone hydrochloride: current generic prescribing information — mechanism explanation — DailyMed / Sun. Checked 2026-10-24.
- Vivitrol: current prescribing information — mechanism explanation — DailyMed / Alkermes. Checked 2026-10-24.
- Nortriptyline 10 mg Film-coated Tablets: UK SmPC — mechanism explanation — Blackrock Pharmaceuticals Ltd / electronic medicines compendium. Checked 2026-10-24.
- Nortriptyline 25 mg — UK SmPC — Blackrock Pharmaceuticals Ltd / emc. Checked 2026-10-17.
- Nortriptyline — patient leaflet — Blackrock Pharmaceuticals Ltd / emc. Checked 2026-10-17.
- NHS: How and when to take nortriptyline — NHS. Checked 2026-10-17.
- NHS: About nortriptyline — NHS. Checked 2026-10-17.
- Nortriptyline 50 mg film-coated tablets — SmPC — Flamingo Pharma (UK) Ltd (emc). Checked 2026-10-17.
- Nortriptyline 10 mg/5 ml oral solution — discontinued product record — Colonis Pharma Ltd (emc). Checked 2026-10-17.
- Nortriptyline 25 mg/5 ml oral solution — discontinued product record — Colonis Pharma Ltd (emc). Checked 2026-10-17.
- Nortriptyline oral solutions: discontinuation — MSN/2024/061 — DHSC / NHS England medicines supply notification, hosted by NHS North East London ICB. Checked 2026-10-17.
- Nortriptyline hydrochloride capsules prescribing information — mechanism explanation — National Library of Medicine, DailyMed. Checked 2026-10-24.
- Nortriptyline: FDA prescribing information — US Food and Drug Administration. Checked 2026-10-17.
- Nortriptyline: verified neutral parent, PubChem CID 4543 — NCBI PubChem. Checked 2026-10-17.
- Zyprexa coated tablets — UK SmPC — Neon Healthcare Ltd. Checked 2026-10-17.
- About olanzapine — NHS. Checked 2026-10-17.
- Taking olanzapine — NHS. Checked 2026-10-17.
- Olanzapine side effects — NHS. Checked 2026-10-17.
- Olanzapine in pregnancy and breastfeeding — NHS. Checked 2026-10-17.
- Olanzapine interactions — NHS. Checked 2026-10-17.
- Zyprexa Velotab 10 mg orodispersible tablets — UK SmPC — Neon Healthcare Limited. Checked 2026-10-17.
- Zypadhera 210 mg, 300 mg and 405 mg powder and solvent for prolonged-release injection — UK SmPC — Neon Healthcare Limited. Checked 2026-10-17.
- Xyquila 10 mg powder for solution for injection — UK SmPC — Eramol UK Ltd. Checked 2026-10-17.
- Zyprexa (olanzapine): prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Cole et al. (2024): injectable olanzapine with or without a benzodiazepine in the emergency department — Annals of Emergency Medicine. Checked 2026-10-28.
- ACEP clinical policy: severe agitation in adult emergency-department patients (approved October 2023; published January 2024) — American College of Emergency Physicians. Checked 2026-10-28.
- PubChem: olanzapine, CID 135398745 — NCBI PubChem. Checked 2026-10-16.
- Trileptal tablets — UK patient leaflet — Novartis Ireland Limited. Checked 2026-10-17.
- Trileptal 60 mg/mL oral suspension — UK SmPC — Electronic Medicines Compendium — marketing-authorisation holder product information. Checked 2026-10-17.
- Trileptal 60 mg/mL oral suspension — UK patient leaflet — Electronic Medicines Compendium — marketing-authorisation holder product information. Checked 2026-10-17.
- Oxcarbazepine: current prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Oxcarbazepine: verified neutral parent, PubChem CID 34312 — NCBI PubChem. Checked 2026-10-17.
- Invega 6 mg prolonged-release tablets — UK SmPC — Janssen-Cilag Limited. Checked 2026-10-17.
- Invega 3 mg, 6 mg and 9 mg tablets — UK patient leaflet — Janssen-Cilag Limited. Checked 2026-10-17.
- Xeplion 150 mg — UK SmPC — Janssen-Cilag Limited. Checked 2026-10-17.
- Xeplion 50, 75, 100 and 150 mg — UK patient leaflet — Janssen-Cilag Limited. Checked 2026-10-17.
- Trevicta 525 mg — UK SmPC — Janssen-Cilag Limited. Checked 2026-10-17.
- Trevicta 175, 263, 350 and 525 mg — UK patient leaflet — Janssen-Cilag Limited. Checked 2026-10-17.
- Byannli 700 mg — UK SmPC — Janssen-Cilag Limited. Checked 2026-10-17.
- Byannli 700 and 1000 mg — UK patient leaflet — Janssen-Cilag Limited. Checked 2026-10-17.
- Invega (paliperidone) extended-release tablets: prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Invega Sustenna (paliperidone palmitate): prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Paliperidone: verified neutral parent, PubChem CID 115237 — NCBI PubChem. Checked 2026-10-17.
- Seroxat 20 mg: UK SmPC — SmithKline Beecham Limited / emc. Checked 2026-10-17.
- Seroxat 30 mg: discontinued product record — SmithKline Beecham Limited / emc. Checked 2026-10-17.
- Seroxat: patient leaflet — GlaxoSmithKline / emc. Checked 2026-10-17.
- NHS: Paroxetine — NHS. Checked 2026-10-17.
- Paxil prescribing information — mechanism explanation — U.S. Food and Drug Administration. Checked 2026-10-24.
- Paroxetine drug information — mechanism explanation — National Library of Medicine, MedlinePlus. Checked 2026-10-24.
- DailyMed: Paxil CR controlled-release prescribing information, revised September 2026 — NLM DailyMed. Checked 2026-10-16.
- PubChem: paroxetine neutral parent compound, CID 43815 — NCBI PubChem. Checked 2026-10-16.
- Nardil 15 mg — UK SmPC — Neon Healthcare Ltd / emc. Checked 2026-10-17.
- Nardil 15 mg — patient leaflet — Neon Healthcare Ltd / emc. Checked 2026-10-17.
- NHS SPS: MAOI to other antidepressants, switching in adults — NHS Specialist Pharmacy Service. Checked 2026-10-17.
- Hull and East Riding: Phenelzine prescribing framework (2021) — Hull and East Riding Prescribing Committee / NHS. Checked 2026-10-17.
- Nardil prescribing information — mechanism explanation — National Library of Medicine, DailyMed. Checked 2026-10-24.
- Phenelzine: verified neutral parent, PubChem CID 3675 — NCBI PubChem. Checked 2026-10-17.
- Hypovase 0.5 mg tablets: SmPC, sections 1–5 and 9–10 — Pfizer Limited / electronic medicines compendium. Checked 2026-10-17.
- Hypovase 0.5 mg tablets: patient leaflet, sections 1–4 — Pfizer Limited / electronic medicines compendium. Checked 2026-10-17.
- Prazosin for PTSD-related nightmares: indication, off-label status and treatment context — NHS Highland / Right Decisions. Checked 2026-10-17.
- Prazosin hydrochloride: prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Prazosin: patient information — mechanism explanation — NIH / MedlinePlus. Checked 2026-10-24.
- Clinician’s Guide to Medications for PTSD — mechanism explanation — US Department of Veterans Affairs. Checked 2026-10-24.
- Raskind and colleagues: A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder — mechanism explanation — Primary clinical trial, Biological Psychiatry / NLM PubMed. Checked 2026-10-24.
- Prazosin: verified neutral parent, PubChem CID 4893 — NCBI PubChem. Checked 2026-10-17.
- Lyrica 25–300 mg capsules: patient leaflet, sections 1–4 — Viatris Products Limited / electronic medicines compendium. Checked 2026-10-17.
- Lyrica 20 mg/ml oral solution: SmPC, sections 2 and 4 — Viatris Products Limited / electronic medicines compendium. Checked 2026-10-17.
- Side effects of pregabalin — NHS. Checked 2026-10-17.
- Pregabalin: reports of severe respiratory depression — MHRA. Checked 2026-10-17.
- Pregabalin and risks in pregnancy — MHRA. Checked 2026-10-17.
- Lyrica capsules and oral solution: current prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Lyrica: FDA prescribing information, April 2025 — US Food and Drug Administration. Checked 2026-10-17.
- Pregabalin: verified neutral parent, PubChem CID 5486971 — NCBI PubChem. Checked 2026-10-17.
- Inderal 40 mg film-coated tablets: SmPC, sections 1–5 and 9 — Atnahs Pharma UK Ltd / electronic medicines compendium. Checked 2026-10-17.
- Common questions about propranolol — NHS. Checked 2026-10-17.
- How and when to take propranolol — NHS. Checked 2026-10-17.
- Side effects of propranolol — NHS. Checked 2026-10-17.
- Who can and cannot take propranolol — NHS. Checked 2026-10-17.
- Propranolol: pregnancy and breastfeeding — NHS. Checked 2026-10-17.
- Propranolol hydrochloride tablets: prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Propranolol: patient information — mechanism explanation — NIH / MedlinePlus. Checked 2026-10-24.
- About propranolol — mechanism explanation — NHS. Checked 2026-10-24.
- Propranolol: current selected US product prescribing information — US National Library of Medicine / DailyMed. Checked 2026-10-17.
- Propranolol: FDA reference-product prescribing information — US Food and Drug Administration. Checked 2026-10-17.
- Propranolol: PubChem CID 4946 — NCBI PubChem. Checked 2026-10-17.
- Seroquel XL prolonged-release tablets — UK SmPC — Luye Pharma Limited. Checked 2026-10-17.
- Quetiapine — NHS. Checked 2026-10-17.
- Seroquel XL 50–400 mg tablets — patient leaflet — Luye Pharma Limited. Checked 2026-10-17.
- Seroquel (quetiapine) prescribing information — mechanism explanation — U.S. National Library of Medicine, DailyMed. Checked 2026-10-24.
- FDA: Seroquel immediate-release prescribing information and Medication Guide — Official labeling / National Library of Medicine. Checked 2026-10-16.
- PubChem: Quetiapine parent compound and 2D record — NCBI PubChem. Checked 2026-10-16.
- Lustral 50 mg: UK SmPC — Viatris Products Limited / emc. Checked 2026-10-17.
- Lustral: patient leaflet — Viatris Products Limited / emc. Checked 2026-10-17.
- NHS: Sertraline — NHS. Checked 2026-10-17.
- Sertraline 20 mg/mL concentrate for oral solution — Rosemont UK SmPC — Electronic Medicines Compendium — marketing-authorisation holder product information. Checked 2026-10-17.
- Sertraline 20 mg/mL concentrate — Rosemont UK patient leaflet — Electronic Medicines Compendium — marketing-authorisation holder product information. Checked 2026-10-17.
- Sertraline 50 mg/5 mL oral suspension — Colonis UK SmPC — Electronic Medicines Compendium — marketing-authorisation holder product information. Checked 2026-10-17.
- Zoloft prescribing information — mechanism explanation — U.S. Food and Drug Administration. Checked 2026-10-24.
- Sertraline patient information — MedlinePlus — National Library of Medicine. Checked 2026-10-16.
- DailyMed: Zoloft product label — Official labeling / National Library of Medicine. Checked 2026-10-16.
- PubChem: Sertraline parent compound and 2D record — NCBI PubChem. Checked 2026-10-16.
- Tranylcypromine 10 mg — UK SmPC — Blackrock Pharmaceuticals Limited / emc. Checked 2026-10-17.
- Parnate / Tranylcypromine 10 mg — UK SmPC — Mercury Pharmaceuticals Ltd / ADVANZ Pharma / emc. Checked 2026-10-17.
- Tranylcypromine 10 mg — patient leaflet — Blackrock Pharmaceuticals Limited / emc. Checked 2026-10-17.
- Parnate prescribing information — mechanism explanation — National Library of Medicine, DailyMed. Checked 2026-10-24.
- Tranylcypromine: verified neutral parent, PubChem CID 5530 — NCBI PubChem. Checked 2026-10-17.
- Trazodone 50 mg — UK SmPC — Waymade PLC trading as Sovereign Medical / emc. Checked 2026-10-17.
- Trazodone 100 mg — UK SmPC — Waymade PLC trading as Sovereign Medical / emc. Checked 2026-10-17.
- Trazodone capsules — patient leaflet — Waymade PLC trading as Sovereign Medical / emc. Checked 2026-10-17.
- NHS: Trazodone — NHS. Checked 2026-10-17.
- Trazodone 150 mg tablets — UK SmPC — Milpharm Limited / emc. Checked 2026-10-17.
- Trazodone hydrochloride tablets prescribing information — mechanism explanation — National Library of Medicine, DailyMed. Checked 2026-10-24.
- Trazodone: verified neutral parent, PubChem CID 5533 — NCBI PubChem. Checked 2026-10-17.
- About valproic acid — NHS. Checked 2026-10-17.
- Depakote 250 mg Tablets: UK Summary of Product Characteristics — mechanism explanation — Sanofi / electronic Medicines Compendium. Checked 2026-10-24.
- Depakote 250 mg and 500 mg tablets — UK patient leaflet — Sanofi. Checked 2026-10-17.
- Valproate: reproductive risks — MHRA. Checked 2026-10-17.
- Valproate: two-specialist review for initiation, not existing male treatment — MHRA. Checked 2026-10-17.
- Valproate use in men: precautionary contraception advice — MHRA. Checked 2026-10-17.
- Valproic acid and sodium valproate monitoring — NHS Specialist Pharmacy Service. Checked 2026-10-17.
- Valproate preparations: current prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Valproate preparations: verified neutral parent, PubChem CID 3121 — NCBI PubChem. Checked 2026-10-17.
- Efexor XL 150 mg: UK SmPC — Viatris / emc. Checked 2026-10-17.
- Efexor XL: patient leaflet — Viatris / emc. Checked 2026-10-17.
- NHS: Venlafaxine — NHS. Checked 2026-10-17.
- Venlafaxine 75 mg immediate-release tablets — Dexcel UK SmPC — Electronic Medicines Compendium — marketing-authorisation holder product information. Checked 2026-10-17.
- Venlafaxine 37.5 mg and 75 mg tablets — Dexcel UK patient leaflet — Electronic Medicines Compendium — marketing-authorisation holder product information. Checked 2026-10-17.
- Venlafaxine XL 37.5 mg prolonged-release capsules — Genus UK SmPC — Electronic Medicines Compendium — marketing-authorisation holder product information. Checked 2026-10-17.
- Effexor XR prescribing information — mechanism explanation — U.S. Food and Drug Administration. Checked 2026-10-24.
- MHRA Safety Roundup: ioflupane — venlafaxine and other SNRIs may affect DAT scan interpretation — Medicines and Healthcare products Regulatory Agency. Checked 2026-11-06.
- DailyMed: Effexor XR extended-release capsules — NLM DailyMed. Checked 2026-10-16.
- PubChem: Venlafaxine parent compound and verified 2D record — NCBI PubChem. Checked 2026-10-16.
- Brintellix — UK SmPC — Lundbeck Limited / emc. Checked 2026-10-17.
- Brintellix — patient leaflet — Lundbeck Limited / emc. Checked 2026-10-17.
- NICE TA367: Vortioxetine recommendation — NICE. Checked 2026-10-17.
- NICE TA367: Consideration of evidence — NICE. Checked 2026-10-17.
- Trintellix prescribing information — mechanism explanation — National Library of Medicine, DailyMed. Checked 2026-10-24.
- Vortioxetine: verified neutral parent, PubChem CID 9966051 — NCBI PubChem. Checked 2026-10-17.
- NHS: common questions about zolpidem — NHS. Checked 2026-10-17.
- Zolpidem tartrate 10 mg tablets — SmPC, sections 4.1–4.9, 5.1–5.2 and 7–10 — Zentiva Pharma UK Limited. Checked 2026-10-17.
- Zolpidem 5 mg and 10 mg tablets — patient leaflet, sections 1–4 and 6 — Zentiva Pharma UK Limited. Checked 2026-10-17.
- Ambien: current prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Zolpidem: MedlinePlus Drug Information — mechanism explanation — US National Library of Medicine / MedlinePlus. Checked 2026-10-24.
- Zolpidem: verified neutral parent, PubChem CID 5732 — NCBI PubChem. Checked 2026-10-17.
- Risperidone 1 mg/mL oral solution — UK SmPC — Milpharm Limited. Checked 2026-10-17.
- About risperidone — NHS. Checked 2026-10-17.
- Taking risperidone — NHS. Checked 2026-10-17.
- Risperidone side effects — NHS. Checked 2026-10-17.
- Risperidone in pregnancy and breastfeeding — NHS. Checked 2026-10-17.
- Risperidone interactions — NHS. Checked 2026-10-17.
- Risperdal Consta 50 mg — UK SmPC — Janssen-Cilag Limited. Checked 2026-10-17.
- Risperdal Consta 25, 37.5 and 50 mg — UK patient leaflet — Janssen-Cilag Limited. Checked 2026-10-17.
- Okedi 75 mg — UK SmPC — Laboratorios Farmacéuticos Rovi, S.A. / Orion Pharma UK. Checked 2026-10-17.
- Okedi 100 mg — UK patient leaflet — Laboratorios Farmacéuticos Rovi, S.A. / Orion Pharma UK. Checked 2026-10-17.
- Risperdal (risperidone): prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- PubChem: risperidone, CID 5073 — NCBI PubChem. Checked 2026-10-16.
- Focalin XR 10mg capsules (Imported (United States)): actual medicinal product — NHS Specialist Pharmacy Service. Checked 2026-10-17.
- Focalin XR (dexmethylphenidate): prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Focalin (dexmethylphenidate) tablets: prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Dexmethylphenidate: patient medicine information — American Society of Health-System Pharmacists / MedlinePlus. Checked 2026-10-17.
- dm+d Implementation Guide (Primary Care), version 2.0 — NHS Digital / NHS Business Services Authority. Checked 2026-10-17.
- Unlicensed specials and imports — Community Pharmacy England. Checked 2026-10-17.
- Adderall XR 5mg capsules (Imported (United States)): actual medicinal product — NHS Specialist Pharmacy Service. Checked 2026-10-17.
- Dextroamphetamine and amphetamine: patient medicine information — American Society of Health-System Pharmacists / MedlinePlus. Checked 2026-10-17.
- Oxford Health NHS Foundation Trust formulary: ADHD medicines — Oxford Health NHS Foundation Trust. Checked 2026-10-17.
- Rxulti 0.25 mg film-coated tablets: UK Summary of Product Characteristics — Otsuka Pharmaceutical Netherlands B.V. / MHRA. Checked 2026-10-18.
- Rxulti 0.5 mg film-coated tablets: UK Summary of Product Characteristics — Otsuka Pharmaceutical Netherlands B.V. / MHRA. Checked 2026-10-18.
- Rxulti 1 mg film-coated tablets: UK Summary of Product Characteristics — Otsuka Pharmaceutical Netherlands B.V. / MHRA. Checked 2026-10-18.
- Rxulti 2 mg film-coated tablets: UK Summary of Product Characteristics — Otsuka Pharmaceutical Netherlands B.V. / MHRA. Checked 2026-10-18.
- Rxulti 3 mg film-coated tablets: UK Summary of Product Characteristics — Otsuka Pharmaceutical Netherlands B.V. / MHRA. Checked 2026-10-18.
- Rxulti 4 mg film-coated tablets: UK Summary of Product Characteristics — Otsuka Pharmaceutical Netherlands B.V. / MHRA. Checked 2026-10-18.
- Rxulti 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg film-coated tablets: patient leaflet — Otsuka Pharmaceutical Netherlands B.V. / MHRA. Checked 2026-10-18.
- UK-wide licensing for human medicines — Medicines and Healthcare products Regulatory Agency. Checked 2026-10-17.
- MHRA authorised product category lists — Medicines and Healthcare products Regulatory Agency. Checked 2026-11-15.
- MHRA Category 1 product list: Rxulti authorisations — MHRA. Checked 2026-10-18.
- Rexulti (brexpiprazole): prescribing information — mechanism explanation — US National Library of Medicine / DailyMed. Checked 2026-10-24.
- Ketalar 50 mg/ml: UK Summary of Product Characteristics (text revised October 2024) — Pfizer / electronic medicines compendium. Checked 2026-10-19.
- Spravato 28 mg nasal spray: UK Summary of Product Characteristics — Janssen-Cilag / electronic medicines compendium. Checked 2026-10-19.
- Ketamine: updated government review of use, harms and controlled-drug status — Advisory Council on the Misuse of Drugs / GOV.UK. Checked 2026-10-19.
- Ketamine and neural changes: animal research and its limits — National Institute of Mental Health. Checked 2026-10-19.
- Ketamine versus ECT for nonpsychotic treatment-resistant major depression (randomised trial, 2023) — Anand and colleagues; New England Journal of Medicine / PubMed. Checked 2026-10-19.
- Oral prolonged-release ketamine for treatment-resistant depression (randomised trials, 2026) — Walter and colleagues; JAMA Network Open / PubMed. Checked 2026-10-19.
- CBT after ketamine: small proof-of-concept randomised clinical trial — Wilkinson and colleagues; Psychotherapy and Psychosomatics / PubMed. Checked 2026-10-19.
- NICE TA854: esketamine for treatment-resistant depression — National Institute for Health and Care Excellence. Checked 2026-10-19.
- Ketalar: current US prescribing information (revised March 2026) — DailyMed / US National Library of Medicine. Checked 2026-10-19.
- Ketamine Lifts Depression via a Byproduct of its Metabolism — mechanism explanation — National Institute of Mental Health. Checked 2026-10-24.
- Multiple mechanisms of ketamine blockade of N-methyl-D-aspartate receptors — mechanism explanation — Orser and colleagues, Anesthesiology; indexed by National Library of Medicine. Checked 2026-10-24.
- Structural basis for channel gating and blockade in tri-heteromeric GluN1-2B-2D NMDA receptor — mechanism explanation — Kang and colleagues, Neuron; NIH-funded primary study archived by National Library of Medicine. Checked 2026-10-24.
- MHRA-agreed Spravato Register and Alert System requirements — MHRA / Janssen direct healthcare professional communication. Checked 2026-10-19.
- Spravato: UK patient risk-minimisation guide (September 2025) — Janssen-Cilag / electronic medicines compendium. Checked 2026-10-19.
- NICE TA899: imminent suicide risk appraisal, terminated without a recommendation — National Institute for Health and Care Excellence. Checked 2026-10-19.
- SMC2258: esketamine for treatment-resistant depression in NHS Scotland — Scottish Medicines Consortium. Checked 2026-10-19.
- SMC2539: acute psychiatric-emergency indication, not recommended after non-submission — Scottish Medicines Consortium. Checked 2026-10-19.
- Esketamine: Welsh appraisal status and NICE TA854 — All Wales Therapeutics and Toxicology Centre. Checked 2026-10-19.
- Northern Ireland: not-recommended technology appraisals, including TA854 — Department of Health / HSCNI Strategic Planning and Performance Group. Checked 2026-10-19.
- Spravato: current US prescribing information (revised March 2026) — DailyMed / US National Library of Medicine. Checked 2026-10-19.
- DSM hypomania criteria comparison — SAMHSA / National Library of Medicine. Checked 2026-10-19.
- Bipolar I disorder: manic and hypomanic episodes — SAMHSA / National Library of Medicine. Checked 2026-10-19.
- Bipolar disorder — let’s talk about it — Birmingham and Solihull Mental Health NHS Foundation Trust. Checked 2026-10-19.
- NIH study reveals differences in brain activity in children with anhedonia — National Institute of Mental Health. Checked 2026-10-19.
- NHS ICD-10 5th Edition: F98.9 — NHS England classification browser. Checked 2026-10-19.
- National Clinical Coding Standards ICD-10 5th Edition (2026), version 12.0; NOS convention — NHS England. Checked 2026-10-19.
- Children and Mental Health: Is This Just a Stage? — NIMH. Checked 2026-10-19.
- NHS: Cognitive behavioural therapy (CBT) — NHS. Checked 2026-10-19.
- Psychotherapies — National Institute of Mental Health. Checked 2026-11-14.
- VA/DoD: Management of Major Depressive Disorder — Provider Summary — VA/DoD. Checked 2026-10-19.
- Kovacs M et al. Depressed outpatients treated with cognitive therapy or pharmacotherapy. A one-year follow-up — Original research, indexed in PubMed. Checked 2026-10-19.
- Greater Manchester Mental Health NHS Foundation Trust: Dialectical Behaviour Therapy — Greater Manchester Mental Health NHS Foundation Trust. Checked 2026-10-19.
- Humber Teaching NHS Foundation Trust: Dialectical Behaviour Therapy Leaflet — Humber Teaching NHS Foundation Trust. Checked 2026-10-19.
- Linehan MM et al. Cognitive-behavioral treatment of chronically parasuicidal borderline patients — Original research, indexed in PubMed. Checked 2026-10-19.
- Self-harm: assessment, management and preventing recurrence — recommendations — NICE. Checked 2026-10-30.
- VA National Center for PTSD: Prolonged Exposure for PTSD — VA National Center for PTSD. Checked 2026-10-19.
- Eye Movement Desensitization and Reprocessing (EMDR) for PTSD — VA National Center for PTSD. Checked 2026-11-14.
- Eye Movement Desensitization and Reprocessing for PTSD — professional overview — VA National Center for PTSD. Checked 2026-11-14.
- VA National Center for PTSD: Overview of Psychotherapy for PTSD — VA National Center for PTSD. Checked 2026-10-19.
- Shapiro F. Eye movement desensitization: a new treatment for post-traumatic stress disorder — Shapiro F. Eye movement desensitization. Checked 2026-10-19.
- VA: Acceptance and Commitment Therapy for Depression — Clinicians Fact Sheet — VA. Checked 2026-10-19.
- Chronic primary pain: ACT from age 16 — NICE. Checked 2026-10-30.
- Walser RD et al. Training in and implementation of Acceptance and Commitment Therapy for depression in the Veterans Health Administration: therapist and patient outcomes — Walser RD et al. Training in and implementation of Acceptance and Commitment Therapy for depression in the Veterans Health Administration. Checked 2026-10-19.
- Camden and Islington NHS Talking Therapies: Interpersonal Psychotherapy — Camden and Islington NHS Talking Therapies. Checked 2026-10-19.
- Elkin I et al. National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments — Original research, indexed in PubMed. Checked 2026-10-19.
- National Child Traumatic Stress Network: Trauma-Focused Cognitive Behavioral Therapy — National Child Traumatic Stress Network. Checked 2026-10-19.
- NCTSN: Trauma-Focused Cognitive Behavioral Therapy — 2026 Fact Sheet — NCTSN. Checked 2026-10-19.
- Cohen JA et al. A multisite, randomized controlled trial for children with sexual abuse-related PTSD symptoms — Original research, indexed in PubMed. Checked 2026-10-19.
- VA National Center for PTSD: PTSD in Children and Teens — VA National Center for PTSD. Checked 2026-10-19.
- VA National Center for PTSD: Cognitive Processing Therapy for PTSD — VA National Center for PTSD. Checked 2026-10-19.
- NHS Education for Scotland: The Matrix — Cognitive Processing Therapy — NHS Education for Scotland. Checked 2026-10-19.
- Resick PA and Schnicke MK. Cognitive processing therapy for sexual assault victims — pubmed.ncbi.nlm.nih.gov. Checked 2026-10-19.
- Foa EB et al. Treatment of posttraumatic stress disorder in rape victims: a comparison between cognitive-behavioral procedures and counseling — Foa EB et al. Treatment of posttraumatic stress disorder in rape victims. Checked 2026-10-19.
- VA/DoD: Management of Chronic Insomnia Disorder and Obstructive Sleep Apnea — Provider Summary — VA/DoD. Checked 2026-10-19.
- VA Mobile: Insomnia Coach — VA Mobile. Checked 2026-10-19.
- Morin CM et al. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial — Morin CM et al. Behavioral and pharmacological therapies for late-life insomnia. Checked 2026-10-19.
- North London NHS Foundation Trust: Family therapy — North London NHS Foundation Trust. Checked 2026-10-19.
- NICE CG178: Psychosis and schizophrenia in adults — Psychological therapy — NICE CG178. Checked 2026-10-19.
- Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust: Family Therapy — Information leaflet — Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust. Checked 2026-10-19.
- Miklowitz DJ et al. A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder — Original research, indexed in PubMed. Checked 2026-10-19.
- NCCIH: Meditation and Mindfulness — Effectiveness and Safety — NCCIH. Checked 2026-10-19.
- Teasdale JD et al. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy — Original research, indexed in PubMed. Checked 2026-10-19.
- Depression in adults: treatment and management — NICE. Checked 2026-10-30.
- Where to get mental health support – children and young people — NHS. Checked 2026-10-17.
- Autism spectrum disorder in under 19s: recognition, referral and diagnosis (CG128) — NICE. Checked 2026-10-21.
- 0–18 years: making decisions — General Medical Council (GMC). Checked 2026-10-21.
- 0–18 years: principles of confidentiality — General Medical Council (GMC). Checked 2026-10-21.
- A national framework to deliver improved outcomes in all-age autism assessment pathways: guidance for integrated care boards — NHS England. Checked 2026-10-21.
- Mental health support for children — NHS inform Scotland. Checked 2026-10-21.
- Community Focused Schools: multi-agency engagement — CAMHS and school support — Welsh Government. Checked 2026-10-21.
- Child and Adolescent Mental Health Service — Belfast Health and Social Care Trust. Checked 2026-10-21.
- Get urgent mental health help — NHS inform. Checked 2026-10-17.
- How to use your health services — nidirect. Checked 2026-10-17.
- Age of Legal Capacity (Scotland) Act 1991, section 2(4) — UK legislation. Checked 2026-10-21.
- SEND code of practice: 0 to 25 years — Department for Education. Checked 2026-10-30.
- Supporting children’s learning code of practice — consultation — Scottish Government. Checked 2026-10-30.
- Additional learning needs: decision-making and communication — Welsh Government. Checked 2026-10-30.
- Special Educational Needs Regulations — implementation statement — Northern Ireland Assembly. Checked 2026-10-30.
- Cannabis-based products for medicinal use, section on synthetic cannabinoids — NHS England. Checked 2026-11-04.
- Cannabis-based medicinal products, recommendations (NG144) — National Institute for Health and Care Excellence (NICE). Checked 2026-11-04.
- Dronabinol for nightmares in post-traumatic stress disorder, randomised controlled trial (2026) — Nature Medicine via PubMed. Checked 2026-11-04.
- Marinol capsule prescribing information (United States) — US Food and Drug Administration. Checked 2026-11-04.
- Syndros oral solution prescribing information (United States) — DailyMed, US National Library of Medicine. Checked 2026-11-04.
- Dronabinol patient information (United States) — MedlinePlus, US National Library of Medicine. Checked 2026-11-04.
- What to do if someone has a seizure — NHS. Checked 2026-11-04.
- Report a problem with a medicine or medical device — MHRA, GOV.UK. Checked 2026-11-04.
- Five Kinds of Somatic Therapies — practice educational article, 18 September 2024 — Downtown Somatic Therapy (Avi Klein). Checked 2026-11-14.
- SE 101 — description of the approach — Somatic Experiencing International. Checked 2026-11-14.
- About AEDP Psychotherapy — AEDP Institute. Checked 2026-11-14.
- About Sensorimotor Psychotherapy — Sensorimotor Psychotherapy Institute. Checked 2026-11-14.
- What is Gestalt? — Gestalt Institute of Cleveland. Checked 2026-11-14.
- Management of PTSD and Acute Stress Disorder: synopsis of the 2023 VA/DoD guideline — recommendations 8 and 27 — VA National Center for PTSD. Checked 2026-11-14.
- Somatic Experiencing for Posttraumatic Stress Disorder: A Randomized Controlled Outcome Study — Journal of Traumatic Stress. Checked 2026-11-14.
- Somatic Experiencing for patients with low back pain and comorbid posttraumatic stress symptoms — a randomised controlled trial — European Journal of Psychotraumatology. Checked 2026-11-14.
- From Somatic Experiencing to felt safety: assessing the effects of a body-oriented intervention in adults with various degrees of child maltreatment — European Journal of Psychotraumatology. Checked 2026-11-14.
- The effectiveness of accelerated experiential dynamic psychotherapy (AEDP) in private practice settings: A transdiagnostic study conducted within the context of a practice-research network — Psychotherapy. Checked 2026-11-14.
- The long-term outcome of accelerated experiential dynamic psychotherapy: 6- and 12-month follow-up results — Psychotherapy. Checked 2026-11-14.
- Positive emotional processes and outcomes in AEDP: naturalistic study (online 28 July 2025; journal issue June 2026) — Psychotherapy Research. Checked 2026-11-14.
- A Pilot RCT of A Body-Oriented Group Therapy For Complex Trauma Survivors: An Adaptation of Sensorimotor Psychotherapy (online 18 May 2020) — Journal of Trauma & Dissociation. Checked 2026-11-14.
- Use of the Temperament and Character Inventory to describe the effectiveness of Gestalt therapy — Frontiers in Psychiatry. Checked 2026-11-14.
- Code of Ethics — informed consent and ethics of touch (sections III and VIII) — United States Association for Body Psychotherapy. Checked 2026-11-14.
- Types of mental health care providers — Substance Abuse and Mental Health Services Administration. Checked 2026-11-14.
- Understanding the regulation of psychologists — Health and Care Professions Council. Checked 2026-11-14.
- Psychotherapist — checking professional registration — Professional Standards Authority. Checked 2026-11-14.
- Neuroscience: the nervous system — Eunice Kennedy Shriver National Institute of Child Health and Human Development. Checked 2026-11-14.
- PTSD Coach Online: Be in the moment — VA National Center for PTSD. Checked 2026-11-14.
- Auvelity: FDA prescribing information and Medication Guide — U.S. Food and Drug Administration. Checked 2026-11-15.
- Auvelity: current product label — DailyMed, National Library of Medicine. Checked 2026-11-15.
- Dextromethorphan and bupropion: patient information — MedlinePlus, National Library of Medicine. Checked 2026-11-15.
- FDA approval of Auvelity for agitation associated with Alzheimer’s dementia — U.S. Food and Drug Administration. Checked 2026-11-15.
- GEMINI depression study: design and results — Axsome Therapeutics. Checked 2026-11-15.
- MHRA medicine product information search — Medicines and Healthcare products Regulatory Agency. Checked 2026-11-15.
- Marketing authorisations granted in 2026 — Medicines and Healthcare products Regulatory Agency. Checked 2026-11-15.
- Get to Know Your Nerve Cells — NIH — NIGMS. Checked 2026-10-16.
- Nerve Tissue — NIH — National Cancer Institute. Checked 2026-10-16.
- Section on Behavioral Neuroscience: Research — NIH — NIMH. Checked 2026-10-16.
- Neurotransmitter Transporters — David Goodsell / RCSB PDB-101. Checked 2026-10-16.
- The Central Nervous System — NIH — National Cancer Institute. Checked 2026-10-16.
- CNS Anatomy: locations of brain structures — NIH — National Cancer Institute. Checked 2026-10-16.
- How your brain works — Mayo Clinic. Checked 2026-10-16.
- Serotonin Receptor — David Goodsell / RCSB PDB-101. Checked 2026-10-16.
- A neural substrate of prediction and reward — research abstract — Schultz, Dayan and Montague / Science. Checked 2026-10-16.
- Sodium’s Role in Nerve Signaling — archived educational article — NIH — NIGMS. Checked 2026-10-16.
- Voltage-gated Sodium Channels — David Goodsell / RCSB PDB-101. Checked 2026-10-16.
- What Is Pharmacology? — NIH — NIGMS. Checked 2026-10-16.
- Pharmacokinetics — NIH — ClinicalInfo. Checked 2026-10-16.
- Contraindication — NIH — National Cancer Institute. Checked 2026-10-16.
- Drugs and Lactation Database: Glossary — NIH — National Library of Medicine. Checked 2026-10-16.
- Side effect — NIH — National Cancer Institute. Checked 2026-10-16.
- How to access mental health services — NHS. Checked 2026-10-17.
- What is psychological therapy? — NHS inform / NHS 24. Checked 2026-10-17.
- Find the right therapist for you — NHS inform. Checked 2026-10-17.
- Health Board approves permanent GP referral pathway change for routine adult mental health support — Hywel Dda University Health Board. Checked 2026-10-17.
- Support for your mental health — NHS 24. Checked 2026-10-17.
- Moving on to adult mental health services — NHS. Checked 2026-10-17.
- Shared care — professional standards — General Medical Council. Checked 2026-10-17.
- Introducing new medicines in the NHS in the UK - pathway — Department of Health and Social Care. Checked 2026-10-17.
- Scottish Intercollegiate Guidelines Network (SIGN) role in NHS guidelines: FOI release — Scottish Government. Checked 2026-10-17.
- How we decide — Scottish Medicines Consortium. Checked 2026-10-17.
- National Institute for Health and Care Excellence (NICE) guidelines — Welsh Government. Checked 2026-10-17.
- NICE Clinical Guidelines — Northern Ireland Department of Health. Checked 2026-10-17.
- Find product information about medicines — MHRA. Checked 2026-10-17.
- The Yellow Card scheme: guidance for healthcare professionals, patients and the public — MHRA. Checked 2026-10-17.
- Clinical Classifications — NHS England. Checked 2026-10-17.
- ICD: Clinical classifications — Public Health Scotland. Checked 2026-10-17.
- ICD-11 Implementation — Northern Ireland Statistics and Research Agency. Checked 2026-10-17.
- Submitting Mental Health Services Data Set (MHSDS) data — NHS England. Checked 2026-10-17.
- ICD-10 Consolidation 2026 — Public Health Scotland. Checked 2026-10-17.
- Mental Health Bill receives Royal Assent, revolutionising care — Department of Health and Social Care. Checked 2026-10-17.
- The Mental Health Act 2025 (Commencement No. 1) Regulations 2026 — UK legislation. Checked 2026-10-17.
- Mental Health Act 2025 — sections 55 and 56: extent and commencement — UK legislation / The National Archives. Checked 2026-10-17.
- Mental health and wellbeing strategy: Legislative framework — Scottish Government. Checked 2026-10-17.
- Mental Capacity Act Legislation — Northern Ireland Department of Health. Checked 2026-10-17.
- Mental Capacity Act — Northern Ireland Department of Health. Checked 2026-10-17.
- Code of practice: Mental Health Act 1983 — Department of Health and Social Care. Checked 2026-10-17.
- Mental Health Act 1983: code of practice — Welsh Government. Checked 2026-10-17.
- Mental Capacity Act — Social care and support guide — NHS. Checked 2026-10-17.
- HSC Circular MCAU 1/26: Interim Guidance for Practitioners in relation to Deprivation of Liberty — Northern Ireland Department of Health. Checked 2026-10-17.
- [2026] UKSC 16 — Press summary: Attorney General for Northern Ireland devolution reference — UK Supreme Court. Checked 2026-10-17.
Article Information
Article pages list their sources and update dates.

